{"id":32195,"date":"2026-08-30T17:39:20","date_gmt":"2026-08-30T15:39:20","guid":{"rendered":"https:\/\/pi3g.com\/?p=32195"},"modified":"2026-08-30T17:39:23","modified_gmt":"2026-08-30T15:39:23","slug":"what-to-expect-from-cra-enforcement-learning-from-the-mdr","status":"publish","type":"post","link":"https:\/\/pi3g.com\/de\/what-to-expect-from-cra-enforcement-learning-from-the-mdr\/","title":{"rendered":"Was von der Durchsetzung des CRA zu erwarten ist: Lehren aus der MDR"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Based on the provided regulatory frameworks and industry data, the Cyber Resilience Act (CRA) and the Medical Device Regulation (MDR) share a highly aligned structural architecture, despite governing different product categories. Below is a detailed comparison of their similarities, followed by documented examples and consequences related to MDR non-compliance for mid-sized and small companies.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Structural Similarities Between the CRA and MDR<\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Risk-Based Classification Systems<\/strong><br>Both regulations utilize graduated risk tiers that dictate the level of regulatory scrutiny. The CRA classifies products into Default, Important, and Critical categories based on cybersecurity risk and potential harm <a href=\"https:\/\/www.dudkowiak.com\/cybersecurity-in-poland\/cyber-resilience-act-cra\/\">[96]<\/a><a href=\"https:\/\/craevidence.com\/cra-compliance\/product-classification\">[107]<\/a>. This mirrors the MDR\u2019s classification of medical devices into Class I, IIa, IIb, and III based on health risks to patients <a href=\"https:\/\/operonstrategist.com\/eu-mdr-affected-ce-marking\/\">[196]<\/a>. In both frameworks, higher-risk categories trigger mandatory third-party oversight, while lower-risk products may undergo self-assessment <a href=\"https:\/\/www.metricstream.com\/learn\/what-is-the-eu-cyber-resilience-act-cra.html\">[95]<\/a><a href=\"https:\/\/craevidence.com\/cra-compliance\/product-classification\">[107]<\/a><a href=\"https:\/\/operonstrategist.com\/eu-mdr-affected-ce-marking\/\">[196]<\/a>.<\/li>\n\n\n\n<li><strong>Notified Body Oversight &amp; CE Marking<\/strong><br>The CRA explicitly extends the MDR\u2019s established Notified Body model to digital products with connectivity <a href=\"https:\/\/www.ul.com\/resources\/guide-cyber-resilience-act\">[100]<\/a>. Important and Critical CRA products, like Class IIa\u2013III MDR devices, require conformity assessment by an accredited Notified Body before affixing the CE mark <a href=\"https:\/\/www.metricstream.com\/learn\/what-is-the-eu-cyber-resilience-act-cra.html\">[95]<\/a><a href=\"https:\/\/www.dudkowiak.com\/cybersecurity-in-poland\/cyber-resilience-act-cra\/\">[96]<\/a><a href=\"https:\/\/www.emergobyul.com\/resources\/european-medical-devices-regulation-mdr-ce-marking-regulatory-process\">[211]<\/a>. Under both regulations, the CE mark has evolved from a general safety indicator into a legally binding declaration of compliance with essential requirements <a href=\"https:\/\/goregulus.com\/cra-basics\/cra-ce-marking-requirements\/\">[113]<\/a><a href=\"https:\/\/meddeviceguide.com\/blog\/ce-marking-medical-devices-guide\">[198]<\/a>. Manufacturers must also maintain EU Declarations of Conformity and comprehensive technical documentation <a href=\"https:\/\/meddeviceguide.com\/blog\/ce-marking-medical-devices-guide\">[198]<\/a><a href=\"https:\/\/morulaa.com\/eu-mdr-2017-745-medical-device-regulation-ce-marking\/\">[210]<\/a>.<\/li>\n\n\n\n<li><strong>Lifecycle Surveillance &amp; Vigilance Obligations<\/strong><br>Compliance under both frameworks is continuous rather than one-time. The CRA mandates vulnerability handling throughout the product lifecycle, including strict 24-hour early-warning and 72-hour incident-reporting duties for exploited vulnerabilities <a href=\"https:\/\/medtechcybertips.com\/compare\">[50]<\/a><a href=\"https:\/\/digital-strategy.ec.europa.eu\/en\/policies\/cyber-resilience-act\">[94]<\/a>. Similarly, the MDR requires rigorous post-market surveillance (PMS), vigilance reporting, clinical evaluation updates, and Field Safety Corrective Actions (FSCAs) when safety issues emerge <a href=\"https:\/\/health.ec.europa.eu\/document\/download\/af1433fd-ed64-4c53-abc7-612a7f16f976_en?filename=mdcg_2023-3_en.pdf\">[219]<\/a>. Both systems emphasize that market authorization is conditional on ongoing monitoring.<\/li>\n\n\n\n<li><strong>Harmonized Standards &amp; Presumption of Conformity<\/strong><br>Both regulations rely on harmonized European standards to translate essential requirements into actionable technical specifications. Compliance with these standards grants a presumption of conformity, streamlining the certification process <a href=\"https:\/\/digital-strategy.ec.europa.eu\/en\/policies\/cra-standardisation\">[97]<\/a><a href=\"https:\/\/www.securebydesignhandbook.com\/docs\/standards\/eu\/mdr-overview\">[104]<\/a><a href=\"https:\/\/www.cyberassure.com.au\/blog-eu-cyber-resilience-act-guide\">[106]<\/a>. For medical devices, standards like ISO 13485 and IEC 62304 are critical; for digital products under the CRA, cybersecurity-specific harmonized standards serve an equivalent function <a href=\"https:\/\/digital-strategy.ec.europa.eu\/en\/policies\/cra-standardisation\">[97]<\/a><a href=\"https:\/\/www.cyberassure.com.au\/blog-eu-cyber-resilience-act-guide\">[106]<\/a>.<\/li>\n\n\n\n<li><strong>Supply Chain Responsibilities &amp; Traceability<\/strong><br>Economic operator duties are clearly delineated in both regulations. Manufacturers, importers, distributors, and authorized representatives bear specific compliance obligations <a href=\"https:\/\/meddeviceguide.com\/blog\/eu-mdr-prrc-person-responsible-regulatory-compliance-guide\">[364]<\/a>. Both frameworks mandate traceability mechanisms: the MDR requires Unique Device Identification (UDI), while the CRA imposes comparable product identification and documentation requirements to ensure market surveillance authorities can track non-compliant items across borders <a href=\"https:\/\/meddeviceguide.com\/blog\/ce-marking-medical-devices-guide\">[198]<\/a><a href=\"https:\/\/meddeviceguide.com\/blog\/eu-mdr-prrc-person-responsible-regulatory-compliance-guide\">[364]<\/a>.<\/li>\n\n\n\n<li><strong>Enforcement &amp; Penalties<\/strong><br>National competent authorities hold parallel enforcement powers under both regulations. Non-compliance can trigger substantial fines, market withdrawals, import detentions, product seizures, injunctions, and certificate suspensions <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12301760\/\">[28]<\/a><a href=\"https:\/\/pureclinical.eu\/device-certification\/significant-change\/\">[61]<\/a><a href=\"https:\/\/www.dudkowiak.com\/cybersecurity-in-poland\/cyber-resilience-act-cra\/\">[96]<\/a><a href=\"https:\/\/meddeviceguide.com\/blog\/ce-marking-medical-devices-guide\">[198]<\/a>. The CRA adopts a GDPR-style penalty structure (up to \u20ac15 million or 2.5% of global turnover) <a href=\"https:\/\/www.dudkowiak.com\/cybersecurity-in-poland\/cyber-resilience-act-cra\/\">[96]<\/a>, while MDR fines are defined by Member States but include equally severe administrative and financial sanctions <a href=\"https:\/\/resources.altium.com\/p\/mdr-medical-device-development\">[27]<\/a><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12301760\/\">[28]<\/a>. Notably, the CRA explicitly excludes products already regulated under the MDR to prevent regulatory overlap and duplication <a href=\"https:\/\/meddeviceguide.com\/blog\/medical-device-cybersecurity-requirements-compared-fda-eu\">[41]<\/a><a href=\"https:\/\/lthj.qut.edu.au\/article\/download\/3080\/1420\">[47]<\/a><a href=\"https:\/\/www.linkedin.com\/posts\/beat-keller_the-eu-cyber-resilience-act-is-not-applicable-activity-7310554173412970496-6mKk\">[54]<\/a><a href=\"https:\/\/meddeviceguide.com\/blog\/medical-device-cybersecurity-requirements-compared-fda-eu\">[110]<\/a>.<\/li>\n<\/ol>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Examples of Mid-Sized and Small Company Non-Compliance with the MDR &amp; Consequences<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">While high-profile MDR enforcement cases often involve multinational corporations, regulatory data and industry analyses reveal that mid-sized and small manufacturers face severe, frequently underreported consequences for non-compliance. The following patterns and documented cases illustrate the impact:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Certification Refusals &amp; Forced Market Withdrawal<\/strong><br>By February 2026, Notified Bodies had formally refused 989 MDR certification applications <a href=\"https:\/\/zamann-pharma.com\/2026\/08\/04\/medical-device-registration-in-europe-in-year-eu-mdr-ce-marking-eudamed-and-market-access-guide\/\">[201]<\/a>. Emerging post-transition reports indicate that recertification failures and voluntary market withdrawals disproportionately affect low-volume devices produced by smaller manufacturers <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12847439\/\">[293]<\/a>. Devices operating on expired legacy certificates that fail to secure MDR compliance face mandatory removal from the EU market, regardless of company size <a href=\"https:\/\/journals.plos.org\/plosone\/article\/file?type=printable&amp;id=10.1371\/journal.pone.0350175\">[69]<\/a><a href=\"https:\/\/www.elexes.com\/feeds\/blog\/eu-mdr-post-market-surveillance\">[70]<\/a>.<\/li>\n\n\n\n<li><strong>Documented Financial Impact: The \u20ac380,000 Market Withdrawal Case<\/strong><br>A specific documented case highlights how compounding MDR compliance failures can escalate into a multi-market crisis for smaller firms. One manufacturer faced approximately \u20ac380,000 in costs due to forced EU market withdrawal after overlooking critical documentation and post-market surveillance requirements across several jurisdictions <a href=\"https:\/\/tecexglobalcompliance.com\/medical-devices-compliance\/\">[295]<\/a>. This underscores how administrative non-compliance rapidly translates into direct financial losses that can threaten the viability of mid-sized operations.<\/li>\n\n\n\n<li><strong>Certificate Suspension &amp; Audit Rigor<\/strong><br>Notified Bodies have significantly tightened surveillance audits under the MDR. Certificates are routinely restricted, suspended, or withdrawn when clinical evaluations, quality management systems, or technical documentation fail to meet updated standards <a href=\"https:\/\/medicaldeviceslegal.com\/2016\/12\/15\/the-authorities-are-not-your-friend-anymore-and-neither-are-notified-bodies\/\">[199]<\/a><a href=\"https:\/\/meddeviceguide.com\/blog\/eu-mdr-notified-body-conformity-assessment-guide\">[207]<\/a>. For smaller companies lacking dedicated regulatory affairs teams, failing a routine surveillance audit often results in immediate market access loss, as certificates do not automatically transfer and must be re-earned <a href=\"https:\/\/meddeviceguide.com\/blog\/eu-mdr-notified-body-conformity-assessment-guide\">[207]<\/a><a href=\"https:\/\/medicaldeviceslegal.com\/2016\/12\/15\/the-authorities-are-not-your-friend-anymore-and-neither-are-notified-bodies\/\">[347]<\/a>.<\/li>\n\n\n\n<li><strong>Resource Strain &amp; Industry Consolidation<\/strong><br>The MDR transition has triggered structural shifts among smaller manufacturers. Data shows that while SMEs represent only 26% of devices expected on the market, they require 40% of total certificates needed, revealing a disproportionate administrative burden <a href=\"https:\/\/www.mddionline.com\/medical-device-regulations\/when-will-the-eu-mdr-burden-begin-to-ease-\">[343]<\/a>. Additionally, surveys indicate that 30% of smaller businesses initially lacked access to MDR-designated Notified Bodies due to capacity bottlenecks <a href=\"https:\/\/www.medtechdive.com\/news\/legacy-devices-lack-mdr-certificates-medtech-europe\/627439\/\">[319]<\/a>. The extended certification timelines (averaging 19.5\u201321.8 months compared to 6\u201312 months under previous directives) severely strain cash flow, driving market consolidation and quiet exits among companies unable to absorb compliance costs <a href=\"https:\/\/meddeviceguide.com\/blog\/medical-device-mna-funding-investment-guide\">[296]<\/a><a href=\"https:\/\/inxso.pro\/insights\/core-issues-that-terminate-the-mdr-conformity-assessment\/\">[312]<\/a><a href=\"https:\/\/link.springer.com\/article\/10.1007\/s10657-026-09873-3\">[324]<\/a>.<\/li>\n<\/ol>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Critical Reflection<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The structural parallels between the CRA and MDR indicate that the EU is intentionally exporting a proven, risk-proportionate regulatory model to broader digital product categories. However, this replication carries significant implications for smaller enterprises. Unlike large multinationals that can absorb compliance costs or publicize settlements, mid-sized and small companies typically face administrative enforcement that leads to silent market withdrawals, certificate revocations, or acquisition by larger competitors <a href=\"https:\/\/meddeviceguide.com\/blog\/medical-device-mna-funding-investment-guide\">[296]<\/a>. The documented \u20ac380,000 withdrawal case <a href=\"https:\/\/tecexglobalcompliance.com\/medical-devices-compliance\/\">[295]<\/a> and the 989 refused applications <a href=\"https:\/\/zamann-pharma.com\/2026\/08\/04\/medical-device-registration-in-europe-in-year-eu-mdr-ce-marking-eudamed-and-market-access-guide\/\">[201]<\/a> demonstrate that non-compliance consequences are not merely theoretical fines but operational threats that can dismantle smaller businesses.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Furthermore, while the CRA excludes MDR-regulated devices to avoid overlap <a href=\"https:\/\/lthj.qut.edu.au\/article\/download\/3080\/1420\">[47]<\/a><a href=\"https:\/\/www.linkedin.com\/posts\/beat-keller_the-eu-cyber-resilience-act-is-not-applicable-activity-7310554173412970496-6mKk\">[54]<\/a><a href=\"https:\/\/meddeviceguide.com\/blog\/medical-device-cybersecurity-requirements-compared-fda-eu\">[110]<\/a>, digital product manufacturers should anticipate identical compliance pressures: stringent lifecycle monitoring, mandatory Notified Body involvement for higher-risk tiers, and severe penalties for inadequate post-market vigilance. Companies that treat certification as a one-time milestone rather than an ongoing operational requirement will likely face the same market access restrictions and financial penalties documented across the MDR transition period <a href=\"https:\/\/pureclinical.eu\/device-certification\/significant-change\/\">[61]<\/a><a href=\"https:\/\/meddeviceguide.com\/blog\/ce-marking-medical-devices-guide\">[198]<\/a><a href=\"https:\/\/link.springer.com\/article\/10.1007\/s10657-026-09873-3\">[324]<\/a>.<\/p>\n\n\n\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary>Sources<\/summary>\n<p class=\"wp-block-paragraph\"><br>[1] U.S. Chamber of Commerce Comments On Unfair Trade Practices (source nr: 1)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.uschamber.com\/international\/u-s-chamber-comments-re-reviewing-and-identifying-unfair-trade-practices-and-initiating-all-necessary-actions-to-investigate-harm-from-non-reciprocal-trade-arrangements-federal-register-docket-number-ustr-2025-0001\">https:\/\/www.uschamber.com\/international\/u-s-chamber-comments-re-reviewing-and-identifying-unfair-trade-practices-and-initiating-all-necessary-actions-to-investigate-harm-from-non-reciprocal-trade-arrangements-federal-register-docket-number-ustr-2025-0001<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[2] FOREIGN TRADE BARRIERS &#8211; USTR (source nr: 2)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/ustr.gov\/sites\/default\/files\/files\/Press\/Reports\/2025NTE.pdf\">https:\/\/ustr.gov\/sites\/default\/files\/files\/Press\/Reports\/2025NTE.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[3] Global AI Governance &#8211; How EU, U.S., China, and others &#8230; &#8211; Medium (source nr: 3)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/medium.com\/@adnanmasood\/global-ai-governance-how-eu-u-s-6ae739db98cd\">https:\/\/medium.com\/@adnanmasood\/global-ai-governance-how-eu-u-s-6ae739db98cd<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[4, 245] EU4Health work programme for 2025 &#8211; Public Health &#8211; Europa.eu (source nr: 4, 245)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/document\/download\/26284fbb-0c7b-4d4d-ae57-f7f2a47e493f_en?filename=funding_c2025_5148_annex_en.pdf\">https:\/\/health.ec.europa.eu\/document\/download\/26284fbb-0c7b-4d4d-ae57-f7f2a47e493f_en?filename=funding_c2025_5148_annex_en.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[5] PROGRESS REPORT &#8211; AMR Industry Alliance (source nr: 5)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2022\/01\/AMRIA_progress-report_FINAL.pdf\">https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2022\/01\/AMRIA_progress-report_FINAL.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[6] European Innovation Council (EIC) Work Programme 2025 (source nr: 6)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/sciencebusiness.net\/sites\/default\/files\/inline-files\/LAST%20VERSION%20EIC%20WP%202025%20version%20TCs%20incl%20Challenges_0.pdf\">https:\/\/sciencebusiness.net\/sites\/default\/files\/inline-files\/LAST%20VERSION%20EIC%20WP%202025%20version%20TCs%20incl%20Challenges_0.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[7] Cyprus AI Regulation Overview &#8211; The Site on AI Laws and Regulations (source nr: 7)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/regulations.ai\/regulations\/RAI-CY-NA-SUMMARY-2026\">https:\/\/regulations.ai\/regulations\/RAI-CY-NA-SUMMARY-2026<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[8] Cybersecurity Market Size And Share Report, 2026-2033 (source nr: 8)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.grandviewresearch.com\/industry-analysis\/cyber-security-market\">https:\/\/www.grandviewresearch.com\/industry-analysis\/cyber-security-market<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[9] IS AI SOVEREIGNTY POSSIBLE? &#8211; Brookings Institution (source nr: 9)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.brookings.edu\/wp-content\/uploads\/2026\/02\/20260217_AI_sovereignty_final.pdf\">https:\/\/www.brookings.edu\/wp-content\/uploads\/2026\/02\/20260217_AI_sovereignty_final.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[10] Capacity Building in Medical Device Regulatory Inspectorate (source nr: 10)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.um.edu.mt\/library\/oar\/bitstream\/123456789\/141866\/1\/2527MDSPHR663700008247_1.PDF\">https:\/\/www.um.edu.mt\/library\/oar\/bitstream\/123456789\/141866\/1\/2527MDSPHR663700008247_1.PDF<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[11] Report on the assessment of the risk of money laundering and &#8230; (source nr: 11)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/anti-money-laundering.eu\/report-on-the-assessment-of-the-risk-of-money-laundering-and-terrorist-financing-affecting-the-internal-market-and-relating-to-cross-border-activities\">https:\/\/anti-money-laundering.eu\/report-on-the-assessment-of-the-risk-of-money-laundering-and-terrorist-financing-affecting-the-internal-market-and-relating-to-cross-border-activities<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[12] USAID Terminated Awards_2025-03-05.xlsx &#8211; HIV i-Base (source nr: 12)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/i-base.info\/wp-content\/uploads\/2025\/03\/USAID-Terminated-Awards_2025-03-06_Clean.pdf\">https:\/\/i-base.info\/wp-content\/uploads\/2025\/03\/USAID-Terminated-Awards_2025-03-06_Clean.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[13] Our 2026 global cybersecurity report is out. \u201cAnatomy of a Cyber &#8230; (source nr: 13)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.facebook.com\/Kaspersky\/posts\/our-2026-global-cybersecurity-report-is-outanatomy-of-a-cyber-world-pulls-back-t\/1405845548253407\">https:\/\/www.facebook.com\/Kaspersky\/posts\/our-2026-global-cybersecurity-report-is-outanatomy-of-a-cyber-world-pulls-back-t\/1405845548253407<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[14] Nanoprobes and Nanoswitches (source nr: 14)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/ibecbarcelona.eu\/research-groups\/nanoprobes-and-nanoswitches\">https:\/\/ibecbarcelona.eu\/research-groups\/nanoprobes-and-nanoswitches<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[15] Status of Post-Earthquake Recovery and Development Efforts in Haiti (source nr: 15)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/2021-2025.state.gov\/reports\/status-of-post-earthquake-recovery-and-development-efforts-in-haiti\">https:\/\/2021-2025.state.gov\/reports\/status-of-post-earthquake-recovery-and-development-efforts-in-haiti<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[16] Annual Report 2025 SEB (source nr: 16)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/webapp.sebgroup.com\/mb\/mblib.nsf\/dld\/1C740093062958DDC1258DAE003DFAF7?opendocument=\">https:\/\/webapp.sebgroup.com\/mb\/mblib.nsf\/dld\/1C740093062958DDC1258DAE003DFAF7?opendocument=<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[17] Corporate Governance Report 2025 &#8211; QNB (source nr: 17)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.qnb.com\/sites\/qnb\/qnbqatar\/document\/en\/enCG2025\">https:\/\/www.qnb.com\/sites\/qnb\/qnbqatar\/document\/en\/enCG2025<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[18] Artificial intelligence and technological unemployment (source nr: 18)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2199853125001428\">https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2199853125001428<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[19] CYBER CAPABILITIES AND NATIONAL POWER Volume 2 (source nr: 19)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.iiss.org\/globalassets\/media-library---content--migration\/files\/research-papers\/2023\/09\/cyber-capabilities-and-national-power-vol-2\/cyber-capabilities-and-national-power_volume-2.pdf\">https:\/\/www.iiss.org\/globalassets\/media-library&#8212;content&#8211;migration\/files\/research-papers\/2023\/09\/cyber-capabilities-and-national-power-vol-2\/cyber-capabilities-and-national-power_volume-2.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[20] Cybersecurity Statistics 2025: Rising Threats And Industry Impact (source nr: 20)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.fortinet.com\/resources\/cyberglossary\/cybersecurity-statistics\">https:\/\/www.fortinet.com\/resources\/cyberglossary\/cybersecurity-statistics<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[21] Current challenges and increased scrutiny in meeting MDR &#8230; (source nr: 21)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/oriongxp.com\/article\/current-challenges-and-increased-scrutiny-in-meeting-mdr-compliance-for-eu-medical-device-manufactures-importers-and-distributors\">https:\/\/oriongxp.com\/article\/current-challenges-and-increased-scrutiny-in-meeting-mdr-compliance-for-eu-medical-device-manufactures-importers-and-distributors<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[22, 253] Medical Device Compliance: EU MDR \/IVDR &amp; Swiss Market (2025) (source nr: 22, 253)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/decomplix.com\/medical-device-compliance\">https:\/\/decomplix.com\/medical-device-compliance<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[23] MDR Medical Device Regulations &#8211; What Should the CUSTOMER &#8230; (source nr: 23)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.fimet.fi\/mdr-medical-device-regulations-what-should-the-customer-know\">https:\/\/www.fimet.fi\/mdr-medical-device-regulations-what-should-the-customer-know<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[24] Lessons from Recent Medical Device Criminal Resolutions (source nr: 24)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.fdli.org\/2020\/08\/lessons-from-recent-medical-device-criminal-resolutions\">https:\/\/www.fdli.org\/2020\/08\/lessons-from-recent-medical-device-criminal-resolutions<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[25] 4 Key Compliance Issues for Medical Device Companies (source nr: 25)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.greenlight.guru\/blog\/4-key-compliance-issues-for-medical-device-companies\">https:\/\/www.greenlight.guru\/blog\/4-key-compliance-issues-for-medical-device-companies<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[26, 65, 208] The EU Medical Device Regulation ( MDR ): What changes? &#8211; VDE (source nr: 26, 65, 208)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.vde.com\/topics-en\/health\/consulting\/the-eu-medical-device-regulation-mdr-what-changes\">https:\/\/www.vde.com\/topics-en\/health\/consulting\/the-eu-medical-device-regulation-mdr-what-changes<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[27] Understanding MDR : Impacts on Medical Device Development (source nr: 27)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/resources.altium.com\/p\/mdr-medical-device-development\">https:\/\/resources.altium.com\/p\/mdr-medical-device-development<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[28, 43, 103] Cybersecurity requirements for medical devices in the EU and US (source nr: 28, 43, 103)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12301760\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12301760<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[29] Mastering the Complexities of Medical Device Claims (source nr: 29)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/medtechintelligence.com\/feature_article\/mastering-the-complexities-of-medical-device-claims\">https:\/\/medtechintelligence.com\/feature_article\/mastering-the-complexities-of-medical-device-claims<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[30, 117] FDA Warning Letters, Consequences and Costs to the US Medical &#8230; (source nr: 30, 117)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.hilarispublisher.com\/open-access\/fda-warning-letters-consequences-and-costs-to-the-us-medical-device-industry-102529.html\">https:\/\/www.hilarispublisher.com\/open-access\/fda-warning-letters-consequences-and-costs-to-the-us-medical-device-industry-102529.html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[31] Overview of Medical Device Regulations ( MDR ) (source nr: 31)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/rookqs.com\/glossary\/medical-device-regulations-mdr\">https:\/\/rookqs.com\/glossary\/medical-device-regulations-mdr<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[32] MDR 2017\/745 and IVDR: New requirements and compliance (source nr: 32)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/efor-group.com\/en\/mdr-2017-745-ivdr-2017-746-requirements-solutions\">https:\/\/efor-group.com\/en\/mdr-2017-745-ivdr-2017-746-requirements-solutions<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[33] Guidance on medical device compliance and enforcement (GUI-0073) (source nr: 33)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/compliance-enforcement\/information-health-product\/medical-devices\/guidance-medical-device-compliance-enforcement-0073\/response-non-compliance.html\">https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/compliance-enforcement\/information-health-product\/medical-devices\/guidance-medical-device-compliance-enforcement-0073\/response-non-compliance.html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[34] Mapping the regulatory landscape for environmental sustainability of &#8230; (source nr: 34)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/academic.oup.com\/eurpub\/article\/36\/2\/ckaf262\/8438588\">https:\/\/academic.oup.com\/eurpub\/article\/36\/2\/ckaf262\/8438588<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[35] How to Report Medical Device Problems &#8211; FDA (source nr: 35)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.fda.gov\/medical-devices\/medical-device-safety\/medical-device-reporting-mdr-how-report-medical-device-problems\">https:\/\/www.fda.gov\/medical-devices\/medical-device-safety\/medical-device-reporting-mdr-how-report-medical-device-problems<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[36] EU MDR : Definition, Timelines, Requirements, and Compliance (source nr: 36)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/simplerqms.com\/eu-mdr\">https:\/\/simplerqms.com\/eu-mdr<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[37] Legal Implications for Manufacturers and Other Stakeholders Under &#8230; (source nr: 37)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/link.springer.com\/chapter\/10.1007\/978-3-032-03577-6_16\">https:\/\/link.springer.com\/chapter\/10.1007\/978-3-032-03577-6_16<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[38] Healthcare: Medical Devices 2025 &#8211; Chambers Practice Guides (source nr: 38)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/practiceguides.chambers.com\/practice-guides\/comparison\/1140\/17098\/26626-26627-26628-26629-26630\">https:\/\/practiceguides.chambers.com\/practice-guides\/comparison\/1140\/17098\/26626-26627-26628-26629-26630<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[39] Understanding Section 10.4.1 of the EU MDR &#8211; Assent (source nr: 39)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.assent.com\/blog\/understanding-section-10-4-1-of-the-eu-mdr\">https:\/\/www.assent.com\/blog\/understanding-section-10-4-1-of-the-eu-mdr<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[40] Risk-Based Approach &#8211; Johner Institute (source nr: 40)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/blog.johner-institute.com\/quality-management-iso-13485\/risk-based-approach\">https:\/\/blog.johner-institute.com\/quality-management-iso-13485\/risk-based-approach<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[41, 110] FDA \u00a7524B vs EU MDR \/MDCG\/CRA &#8211; MedDeviceGuide (source nr: 41, 110)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/meddeviceguide.com\/blog\/medical-device-cybersecurity-requirements-compared-fda-eu\">https:\/\/meddeviceguide.com\/blog\/medical-device-cybersecurity-requirements-compared-fda-eu<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[42] MDR -IVDR Amendment Proposals: What About Cybersecurity? (source nr: 42)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/plantvision.se\/en\/insights\/articles\/mdr-ivdr-amendment-proposals-what-about-cybersecurity\">https:\/\/plantvision.se\/en\/insights\/articles\/mdr-ivdr-amendment-proposals-what-about-cybersecurity<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[44] EU Cyber Resilience Act and Medical Devices 2026 (source nr: 44)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/nexortest.com\/does-the-eu-cyber-resilience-act-apply-to-your-medical-device-what-the-11-september-2026-deadline-really-means\">https:\/\/nexortest.com\/does-the-eu-cyber-resilience-act-apply-to-your-medical-device-what-the-11-september-2026-deadline-really-means<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[45] Cybersecurity &amp; Privacy for Digital Health Software &#8211; MedQAIR (source nr: 45)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/medqair.com\/cybersecurity-and-privacy\">https:\/\/medqair.com\/cybersecurity-and-privacy<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[46] The Problem the EU Created with the Cyber Resilience Act &#8211; LinkedIn (source nr: 46)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.linkedin.com\/pulse\/problem-eu-created-cyber-resilience-act-raymond-doetjes-mqiqe\">https:\/\/www.linkedin.com\/pulse\/problem-eu-created-cyber-resilience-act-raymond-doetjes-mqiqe<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[47] The Role of Cybersecurity in Medical Devices Regulation (source nr: 47)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/lthj.qut.edu.au\/article\/download\/3080\/1420\">https:\/\/lthj.qut.edu.au\/article\/download\/3080\/1420<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[48] Future Trends in ISO 13485 for Medical Device Suppliers &#8211; Smithers (source nr: 48)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.smithers.com\/resources\/2025\/november\/trends-in-iso-13485-for-medical-device-suppliers\">https:\/\/www.smithers.com\/resources\/2025\/november\/trends-in-iso-13485-for-medical-device-suppliers<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[49, 111] EU Cyber Resilience Act : What to Do Before 2027 &#8211; Strobes Security (source nr: 49, 111)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/strobes.co\/blog\/eu-cyber-resilience-act-what-you-must-do\">https:\/\/strobes.co\/blog\/eu-cyber-resilience-act-what-you-must-do<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[50] FDA 524B vs EU MDR vs EU CRA &#8211; 2026 Cybersecurity Crosswalk (source nr: 50)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/medtechcybertips.com\/compare\">https:\/\/medtechcybertips.com\/compare<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[51] CRA and NIS2 Relationship | Security &amp; Compliance Frameworks (source nr: 51)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.cagripolat.com\/cra\/en\/cra-nis2-directive-relationship-differences-analysis\">https:\/\/www.cagripolat.com\/cra\/en\/cra-nis2-directive-relationship-differences-analysis<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[52] AIB 2025-1 MDCG 2025-6 Interplay between the Medical Devices &#8230; (source nr: 52)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/document\/download\/b78a17d7-e3cd-4943-851d-e02a2f22bbb4_en\">https:\/\/health.ec.europa.eu\/document\/download\/b78a17d7-e3cd-4943-851d-e02a2f22bbb4_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[53] Cybersecurity vulnerability analysis of medical devices purchased &#8230; (source nr: 53)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.nature.com\/articles\/s41598-023-45927-1\">https:\/\/www.nature.com\/articles\/s41598-023-45927-1<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[54] The EU Cyber Resilience Act Is Not Applicable for Medical Devices (source nr: 54)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.linkedin.com\/posts\/beat-keller_the-eu-cyber-resilience-act-is-not-applicable-activity-7310554173412970496-6mKk\">https:\/\/www.linkedin.com\/posts\/beat-keller_the-eu-cyber-resilience-act-is-not-applicable-activity-7310554173412970496-6mKk<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[55] EU MDR , FDA 510(k) and DTAC Cybersecurity Nonconformities (source nr: 55)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/mantrasystems.com\/articles\/eu-mdr-fda-dtac-cybersecurity-nonconformities-recovery\">https:\/\/mantrasystems.com\/articles\/eu-mdr-fda-dtac-cybersecurity-nonconformities-recovery<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[56] Resource Center &#8211; Mender (source nr: 56)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/mender.io\/resources\">https:\/\/mender.io\/resources<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[57] European Union EU MDR &#8211; EC \/ MDCG Medical Device Cybersec\u2026 (source nr: 57)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/mdccrosswalk.com\/standards\/eu\">https:\/\/mdccrosswalk.com\/standards\/eu<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[58] NIS2 and EU Cyber Resilience Act | Understand Their Relationship (source nr: 58)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/hyperproof.io\/understanding-the-relationship-between-nis2-and-the-eu-cyber-resilience-act\">https:\/\/hyperproof.io\/understanding-the-relationship-between-nis2-and-the-eu-cyber-resilience-act<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[59, 99] Cyber Resilience Act : The Complete Survival Guide for Manufacturers (source nr: 59, 99)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.cclab.com\/news\/cyber-resilience-act-the-complete-survival-guide-for-manufacturers\">https:\/\/www.cclab.com\/news\/cyber-resilience-act-the-complete-survival-guide-for-manufacturers<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[60] What is Software as a Medical Device ? &#8211; PTC (source nr: 60)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.ptc.com\/en\/blogs\/medtech\/what-is-software-as-a-medical-device?srsltid=AfmBOopFaSmc7zbxXfPvACeJ9MEL30JgM8fDxop7AC1l3UqFEMEgnBZn\">https:\/\/www.ptc.com\/en\/blogs\/medtech\/what-is-software-as-a-medical-device?srsltid=AfmBOopFaSmc7zbxXfPvACeJ9MEL30JgM8fDxop7AC1l3UqFEMEgnBZn<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[61] Significant Change in Medical Devices Under MDR &#8211; Pure Clinical (source nr: 61)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/pureclinical.eu\/device-certification\/significant-change\">https:\/\/pureclinical.eu\/device-certification\/significant-change<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[62, 202] EU MDR Bottleneck Ahead: Why 2026 Will Be a\u2026 &#8211; QbD Group (source nr: 62, 202)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/qbdgroup.com\/en\/blog\/eu-mdr-bottleneck-2026-medical-device-manufacturers\">https:\/\/qbdgroup.com\/en\/blog\/eu-mdr-bottleneck-2026-medical-device-manufacturers<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[63, 313] Global market and supply chain implications of the European Union &#8230; (source nr: 63, 313)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12849135\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12849135<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[64] EU MDR Transition Deadlines 2027 and 2028 &#8211; MD-Regulatory (source nr: 64)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/mdregulatory.com\/eu-mdr-transition-deadlines\">https:\/\/mdregulatory.com\/eu-mdr-transition-deadlines<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[66] EU MDR : Key Changes and Important Steps + EU MDR Checklist (source nr: 66)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.scilife.io\/blog\/eu-mdr-key-changes-and-important-steps\">https:\/\/www.scilife.io\/blog\/eu-mdr-key-changes-and-important-steps<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[67, 292] CE Marking for Medical Devices: Complete 2026 Guide (source nr: 67, 292)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/blogs.seyecs.com\/ce-marking-for-medical-devices\">https:\/\/blogs.seyecs.com\/ce-marking-for-medical-devices<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[68] Article 10a MDR \/IVDR (source nr: 68)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/document\/download\/b431b10f-8512-4f47-9191-e1b84b2f9a27_en?filename=mdr_qna-article10a_mdr-ivdr_en.pdf\">https:\/\/health.ec.europa.eu\/document\/download\/b431b10f-8512-4f47-9191-e1b84b2f9a27_en?filename=mdr_qna-article10a_mdr-ivdr_en.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[69] Evaluating the impact of the EU Medical Device Regulation ( MDR &#8230; (source nr: 69)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/journals.plos.org\/plosone\/article\/file?type=printable&amp;id=10.1371%2Fjournal.pone.0350175\">https:\/\/journals.plos.org\/plosone\/article\/file?type=printable&amp;id=10.1371%2Fjournal.pone.0350175<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[70] EU MDR Post- Market Surveillance: Complete Compliance Guide (source nr: 70)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.elexes.com\/feeds\/blog\/eu-mdr-post-market-surveillance\">https:\/\/www.elexes.com\/feeds\/blog\/eu-mdr-post-market-surveillance<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[71, 155, 212, 324] Regulatory delays and patent term erosion in medical device &#8230; (source nr: 71, 155, 212, 324)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/link.springer.com\/article\/10.1007\/s10657-026-09873-3\">https:\/\/link.springer.com\/article\/10.1007\/s10657-026-09873-3<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[72] MDR &#8211; Article 2 &#8211; Definitions &#8211; Medical Device Regulation (source nr: 72)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.medical-device-regulation.eu\/2019\/07\/10\/mdr-article-2-definitions\">https:\/\/www.medical-device-regulation.eu\/2019\/07\/10\/mdr-article-2-definitions<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[73] Brace for Impact: The New MDR Transition Periods &#8211; OpenRegulatory (source nr: 73)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/openregulatory.com\/articles\/new-mdr-transition-periods-2023\">https:\/\/openregulatory.com\/articles\/new-mdr-transition-periods-2023<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[74, 184, 328] A review of the literature on the new European Medical Device &#8230; (source nr: 74, 184, 328)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.emerald.com\/ijphm\/article\/19\/1\/1\/1245282\/A-review-of-the-literature-on-the-new-European\">https:\/\/www.emerald.com\/ijphm\/article\/19\/1\/1\/1245282\/A-review-of-the-literature-on-the-new-European<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[75] The EU Medical Device Regulation: What&#8217;s Next? | McDermott (source nr: 75)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.mcdermottlaw.com\/insights\/the-eu-medical-device-regulation-whats-next\">https:\/\/www.mcdermottlaw.com\/insights\/the-eu-medical-device-regulation-whats-next<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[76] europe- mdr -whitepaper-emergo.pdf (source nr: 76)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.emergobyul.com\/sites\/g\/files\/qbfpbp571\/files\/2022-08\/europe-mdr-whitepaper-emergo.pdf\">https:\/\/www.emergobyul.com\/sites\/g\/files\/qbfpbp571\/files\/2022-08\/europe-mdr-whitepaper-emergo.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[77] How to Thrive Amid Looming EU Medical Device and iVD Regulations (source nr: 77)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.qad.com\/blog\/2021\/05\/how-to-thrive-amid-looming-eu-medical-device-and-ivd-regulations\">https:\/\/www.qad.com\/blog\/2021\/05\/how-to-thrive-amid-looming-eu-medical-device-and-ivd-regulations<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[78] EU MDR Article 10a: Supply Chain Discontinuation and Shortage &#8230; (source nr: 78)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/meddeviceguide.com\/blog\/eu-mdr-article-10a-supply-chain-discontinuation-shortage-prevention-guide\">https:\/\/meddeviceguide.com\/blog\/eu-mdr-article-10a-supply-chain-discontinuation-shortage-prevention-guide<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[79] CE Mark Medical Devices: Spot Fakes in 5 Steps &#8211; Kinmed (source nr: 79)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/chinakinmed.com\/en\/article\/ce-marking-medical-devices\">https:\/\/chinakinmed.com\/en\/article\/ce-marking-medical-devices<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[80] Guidance on medical device significant changes under MDR (source nr: 80)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/decomplix.com\/medical-device-significant-changes\">https:\/\/decomplix.com\/medical-device-significant-changes<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[81, 226] SWD( 2022 ) 282 final &#8211; EUR-Lex &#8211; Europa. eu (source nr: 81, 226)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=CELEX%3A52022SC0282\">https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=CELEX%3A52022SC0282<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[82] GxP Compliance Software: eQMS &amp; Document Management (source nr: 82)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/intuitionlabs.ai\/articles\/gxp-compliance-software-eqms-comparison\">https:\/\/intuitionlabs.ai\/articles\/gxp-compliance-software-eqms-comparison<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[83] Vertiv &#8211; Facebook (source nr: 83)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.facebook.com\/vertiv\/posts\/serial-consoles-help-secure-infrastructure-by-isolating-access-to-critical-syste\/1514204167410536\">https:\/\/www.facebook.com\/vertiv\/posts\/serial-consoles-help-secure-infrastructure-by-isolating-access-to-critical-syste\/1514204167410536<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[84] Key to Success: Promotion Guide 2025-26 | PDF | Banks &#8211; Scribd (source nr: 84)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.scribd.com\/document\/839849445\/Key-to-Success-2025-26\">https:\/\/www.scribd.com\/document\/839849445\/Key-to-Success-2025-26<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[85] Arihant indian economy magbook 9789325798076 &#8211; DOKUMEN.PUB (source nr: 85)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/dokumen.pub\/arihant-indian-economy-magbook-9789325798076.html\">https:\/\/dokumen.pub\/arihant-indian-economy-magbook-9789325798076.html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[86] Is de zaak al beklonken? Brede school op sportterrein Succes? (source nr: 86)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.wieringernieuws.nl\/index.php?pagina=Column&amp;optie=Detail&amp;cid=206\">https:\/\/www.wieringernieuws.nl\/index.php?pagina=Column&amp;optie=Detail&amp;cid=206<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[87] Mrunal Sir Latest Handouts (1-21) | PDF | Money &#8211; Scribd (source nr: 87)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.scribd.com\/document\/542806089\/Mrunal-Sir-Latest-Handouts-1-21-1\">https:\/\/www.scribd.com\/document\/542806089\/Mrunal-Sir-Latest-Handouts-1-21-1<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[88] LexForm Legal Blog (source nr: 88)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/lex-form.com\/blog\/index.html\">https:\/\/lex-form.com\/blog\/index.html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[89] NCERT Insights on Indian Economy | PDF | Economics &#8211; Scribd (source nr: 89)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.scribd.com\/document\/649319981\/Magbook-Indian-Economy-Arihant\">https:\/\/www.scribd.com\/document\/649319981\/Magbook-Indian-Economy-Arihant<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[90] How Europe is killing makers and micro-entrepreneurs | Hacker News (source nr: 90)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/news.ycombinator.com\/item?id=49419237\">https:\/\/news.ycombinator.com\/item?id=49419237<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[91] Our Updates 2021 &#8211; Minocha &amp; Company (source nr: 91)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/cajatinminocha.com\/resource\/Updates\/Our_Updates_2021.aspx\">https:\/\/cajatinminocha.com\/resource\/Updates\/Our_Updates_2021.aspx<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[92] Full text of &#8220;Financial Times , 1993, UK, English&#8221; &#8211; Internet Archive (source nr: 92)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/archive.org\/stream\/FinancialTimes1993UKEnglish\/Mar%2001%201993%2C%20Financial%20Times%2C%20%231%2C%20UK%20%28en%29_djvu.txt\">https:\/\/archive.org\/stream\/FinancialTimes1993UKEnglish\/Mar%2001%201993%2C%20Financial%20Times%2C%20%231%2C%20UK%20%28en%29_djvu.txt<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[93] SBI Promotion Test Guide 2018 | PDF | Cheque | Banks &#8211; Scribd (source nr: 93)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.scribd.com\/document\/524809874\/Vikas-2018-Sblc-Bhubaneswar\">https:\/\/www.scribd.com\/document\/524809874\/Vikas-2018-Sblc-Bhubaneswar<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[94] Cyber Resilience Act | Shaping Europe&#8217;s digital future (source nr: 94)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/digital-strategy.ec.europa.eu\/en\/policies\/cyber-resilience-act\">https:\/\/digital-strategy.ec.europa.eu\/en\/policies\/cyber-resilience-act<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[95] What Is the EU Cyber Resilience Act (CRA)? Requirements and &#8230; (source nr: 95)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.metricstream.com\/learn\/what-is-the-eu-cyber-resilience-act-cra.html\">https:\/\/www.metricstream.com\/learn\/what-is-the-eu-cyber-resilience-act-cra.html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[96] Cyber Resilience Act (CRA) | Dudkowiak &amp; Putyra (source nr: 96)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.dudkowiak.com\/cybersecurity-in-poland\/cyber-resilience-act-cra\">https:\/\/www.dudkowiak.com\/cybersecurity-in-poland\/cyber-resilience-act-cra<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[97] Cyber Resilience Act &#8211; Standardisation (source nr: 97)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/digital-strategy.ec.europa.eu\/en\/policies\/cra-standardisation\">https:\/\/digital-strategy.ec.europa.eu\/en\/policies\/cra-standardisation<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[98] The Cyber Resilience Act Explained: What MDMs and Healthcare &#8230; (source nr: 98)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/c2a-sec.com\/the-cyber-resilience-act-explained-what-mdms-and-healthcare-security-leaders-need-to-know\">https:\/\/c2a-sec.com\/the-cyber-resilience-act-explained-what-mdms-and-healthcare-security-leaders-need-to-know<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[100] Guide to the Cyber Resilience Act &#8211; UL Solutions (source nr: 100)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.ul.com\/resources\/guide-cyber-resilience-act\">https:\/\/www.ul.com\/resources\/guide-cyber-resilience-act<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[101] Cyber Resilience Act : Complete Guide for Businesses 2026 (source nr: 101)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.advisori.de\/en\/blog\/cyber-resilience-act-overview-businesses-2026\">https:\/\/www.advisori.de\/en\/blog\/cyber-resilience-act-overview-businesses-2026<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[102] European Cyber Resilience Act (CRA) Compliance | Iterasec Guide (source nr: 102)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/iterasec.com\/blog\/navigating-european-cyber-resilience-act-cra\">https:\/\/iterasec.com\/blog\/navigating-european-cyber-resilience-act-cra<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[104] Medical Device Regulation ( MDR ) &#8211; Secure-by-Design Handbook (source nr: 104)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.securebydesignhandbook.com\/docs\/standards\/eu\/mdr-overview\">https:\/\/www.securebydesignhandbook.com\/docs\/standards\/eu\/mdr-overview<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[105] What the Proposed MDR \/IVDR Simplification Means for Medical &#8230; (source nr: 105)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/biosistemika.com\/blog\/proposed-mdr-ivdr-simplification-means-for-medical-device-and-ivd-manufacturers\">https:\/\/biosistemika.com\/blog\/proposed-mdr-ivdr-simplification-means-for-medical-device-and-ivd-manufacturers<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[106] EU Cyber Resilience Act for Manufacturers | CyberAssure (source nr: 106)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.cyberassure.com.au\/blog-eu-cyber-resilience-act-guide\">https:\/\/www.cyberassure.com.au\/blog-eu-cyber-resilience-act-guide<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[107] CRA Product Classification : Default, Important, Critical (source nr: 107)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/craevidence.com\/cra-compliance\/product-classification\">https:\/\/craevidence.com\/cra-compliance\/product-classification<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[108] The EU Cyber Resilience Act : How to Get Ready by 2027 (source nr: 108)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/underdefense.com\/blog\/the-eu-cyber-resilience-act-how-to-get-ready-by-2027\">https:\/\/underdefense.com\/blog\/the-eu-cyber-resilience-act-how-to-get-ready-by-2027<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[109] Cyber Resilience Act (CRA): Complete Compliance Guide for 2026 (source nr: 109)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.orbiqhq.com\/eu-regulations\/cyber-resilience-act\">https:\/\/www.orbiqhq.com\/eu-regulations\/cyber-resilience-act<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[112] CRA ( Cyber Resilience Act ) Compliance (source nr: 112)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/europeancompliancesuite.com\/cra-cyber-resilience-act-compliance\">https:\/\/europeancompliancesuite.com\/cra-cyber-resilience-act-compliance<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[113] Your Guide to CRA CE Marking Requirements &#8211; Regulus (source nr: 113)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/goregulus.com\/cra-basics\/cra-ce-marking-requirements\">https:\/\/goregulus.com\/cra-basics\/cra-ce-marking-requirements<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[114, 144, 266] The medical device company still does not know when the situation &#8230; (source nr: 114, 144, 266)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.facebook.com\/NBC10Boston\/posts\/the-medical-device-company-still-does-not-know-when-the-situation-will-be-fully-\/1503078941852453\">https:\/\/www.facebook.com\/NBC10Boston\/posts\/the-medical-device-company-still-does-not-know-when-the-situation-will-be-fully-\/1503078941852453<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[115] Late adverse event reporting from medical device manufacturers to &#8230; (source nr: 115)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.bmj.com\/content\/388\/bmj-2024-081518\">https:\/\/www.bmj.com\/content\/388\/bmj-2024-081518<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[116] bsx-20251231 &#8211; SEC.gov (source nr: 116)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/885725\/000088572526000010\/bsx-20251231.htm\">https:\/\/www.sec.gov\/Archives\/edgar\/data\/885725\/000088572526000010\/bsx-20251231.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[118, 145, 156, 302, 352] Form 10-K for ICU Medical Incde filed 02\/19\/2026 (source nr: 118, 145, 156, 302, 352)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/ir.icumed.com\/static-files\/8b1124af-4082-4692-a792-de31bb4958cc\">https:\/\/ir.icumed.com\/static-files\/8b1124af-4082-4692-a792-de31bb4958cc<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[119, 173, 305] FORM 10-K BOSTON SCIENTIFIC CORPORATION (source nr: 119, 173, 305)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/docs.publicnow.com\/viewDoc.aspx?filename=201529%5CEXT%5CC4D3C78FA1FEA55A37E59A9AA801E084E75B655A_619B106ECE302A1A4A538688C067E1A046509E64.PDF\">https:\/\/docs.publicnow.com\/viewDoc.aspx?filename=201529%5CEXT%5CC4D3C78FA1FEA55A37E59A9AA801E084E75B655A_619B106ECE302A1A4A538688C067E1A046509E64.PDF<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[120] FOIA_Received_Log &#8211; FDA (source nr: 120)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.fda.gov\/media\/191404\/download\">https:\/\/www.fda.gov\/media\/191404\/download<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[121] irtc-20251231 &#8211; SEC.gov (source nr: 121)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1388658\/000138865826000011\/irtc-20251231.htm\">https:\/\/www.sec.gov\/Archives\/edgar\/data\/1388658\/000138865826000011\/irtc-20251231.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[122, 152, 161, 353] Form 10-K for Integra Lifesciences Holdings Corp filed 02\/25\/2025 (source nr: 122, 152, 161, 353)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investor.integralife.com\/static-files\/68f476ed-c12b-4dc9-a0e5-e53eeac31a55\">https:\/\/investor.integralife.com\/static-files\/68f476ed-c12b-4dc9-a0e5-e53eeac31a55<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[123] FDA Medical Device Reporting: Adverse Event Rules Under 21 CFR &#8230; (source nr: 123)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/meddeviceguide.com\/blog\/medical-device-adverse-event-reporting-fda-mdr-guide\">https:\/\/meddeviceguide.com\/blog\/medical-device-adverse-event-reporting-fda-mdr-guide<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[124] FDA Issues Warning Letters to Unomedical and Beta Bionics for &#8230; (source nr: 124)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.linkedin.com\/posts\/suzannelevy_more-regarding-cdrh-enforcement-action-activity-7434694741767864320-pLui\">https:\/\/www.linkedin.com\/posts\/suzannelevy_more-regarding-cdrh-enforcement-action-activity-7434694741767864320-pLui<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[125] MEDICAL DEVICE REPORTING (source nr: 125)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.mddionline.com\/business\/medical-device-reporting\">https:\/\/www.mddionline.com\/business\/medical-device-reporting<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[126] What does Medtronic out of regulation warning code mean? (source nr: 126)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.facebook.com\/groups\/341015404031050\/posts\/1170126327786616\">https:\/\/www.facebook.com\/groups\/341015404031050\/posts\/1170126327786616<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[127] horak Attorney at law, Hanover: Medical devices law &#8211; Health law (source nr: 127)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/healthlawyer.de\/Health_lawyer\/Medical_devices\/medical_devices_law.html\">https:\/\/healthlawyer.de\/Health_lawyer\/Medical_devices\/medical_devices_law.html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[128] 2025 Annual Report &#8211; Intuitive Surgical Investor Relations (source nr: 128)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/isrg.intuitive.com\/static-files\/d01bbc25-f8cf-433b-8ebb-b5afc1926236\">https:\/\/isrg.intuitive.com\/static-files\/d01bbc25-f8cf-433b-8ebb-b5afc1926236<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[129] AI Medical Device Cybersecurity: Regulations &amp; Risks &#8211; IntuitionLabs (source nr: 129)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/intuitionlabs.ai\/articles\/cybersecurity-requirements-ai-medical-devices\">https:\/\/intuitionlabs.ai\/articles\/cybersecurity-requirements-ai-medical-devices<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[130] 2019 Boston Scientific Performance Report (source nr: 130)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investors.bostonscientific.com\/~\/media\/Files\/B\/Boston-Scientific-IR-V3\/annual-reports-proxy-statements\/2019_boston-scientific_performance_report.pdf\">https:\/\/investors.bostonscientific.com\/~\/media\/Files\/B\/Boston-Scientific-IR-V3\/annual-reports-proxy-statements\/2019_boston-scientific_performance_report.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[131] Drugs and Devices: Comparison of European and U.S. Approval &#8230; (source nr: 131)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.jacc.org\/doi\/10.1016\/j.jacbts.2016.06.003\">https:\/\/www.jacc.org\/doi\/10.1016\/j.jacbts.2016.06.003<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[132] Pharmaceuticals, Medical Devices and Biologics Regulatory &#8230; &#8211; BCLP (source nr: 132)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.bclplaw.com\/a\/web\/1355\/11-24-09-Drugs-Devices-Regulatory-Policy-Bulletin-Democrat.pdf\">https:\/\/www.bclplaw.com\/a\/web\/1355\/11-24-09-Drugs-Devices-Regulatory-Policy-Bulletin-Democrat.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[133] Emerging Risk Trends in the Medical Device Industry &#8211; Kroll (source nr: 133)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.kroll.com\/en\/publications\/compliance-risk\/emerging-risk-trends-in-the-medical-device-industry\">https:\/\/www.kroll.com\/en\/publications\/compliance-risk\/emerging-risk-trends-in-the-medical-device-industry<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[134] 3B Medical , Inc. dba Reach Health, Inc. &#8211; 725108 &#8211; 05\/20\/2026 | FDA (source nr: 134)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/3b-medical-inc-dba-reach-health-inc-725108-05202026\">https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/3b-medical-inc-dba-reach-health-inc-725108-05202026<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[135] Form 10-K for Intuitive Surgical INC filed 01\/31\/ 2025 (source nr: 135)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/isrg.intuitive.com\/static-files\/3606b65a-c676-47a5-a638-6b53c19b7143\">https:\/\/isrg.intuitive.com\/static-files\/3606b65a-c676-47a5-a638-6b53c19b7143<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[136, 163, 361] Form 10-K for Embecta Corp filed 11\/25\/ 2025 (source nr: 136, 163, 361)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investors.embecta.com\/static-files\/69df98aa-9475-4a51-86a2-0a6321998539\">https:\/\/investors.embecta.com\/static-files\/69df98aa-9475-4a51-86a2-0a6321998539<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[137, 259, 363] 10-K: Annual report [Section 13 and 15(d), not S-K Item 405] (source nr: 137, 259, 363)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investor.resmed.com\/sec-filings\/content\/0000943819-25-000035\/rmd-20250630.htm\">https:\/\/investor.resmed.com\/sec-filings\/content\/0000943819-25-000035\/rmd-20250630.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[138, 365] 10-K: Annual report [Section 13 and 15(d), not S-K Item 405] (source nr: 138, 365)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investors.bd.com\/sec-filings\/all-sec-filings\/content\/0000010795-25-000099\/bdx-20250930.htm\">https:\/\/investors.bd.com\/sec-filings\/all-sec-filings\/content\/0000010795-25-000099\/bdx-20250930.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[139] Royal Philips MARCS-CMS 709948 \u2014 September 09, 2025 &#8211; FDA (source nr: 139)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/royal-philips-709948-09092025\">https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/royal-philips-709948-09092025<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[140, 254] Late adverse event reporting from medical device manufacturers to &#8230; (source nr: 140, 254)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11898541\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11898541<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[141, 358] Form 10-K for Cooper Companies INC filed 12\/05\/ 2025 (source nr: 141, 358)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investor.coopercos.com\/static-files\/4f6e3a4f-c781-4544-aa23-4319053fc08a\">https:\/\/investor.coopercos.com\/static-files\/4f6e3a4f-c781-4544-aa23-4319053fc08a<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[142] The historical evolution of European medical device regulation (source nr: 142)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/pharmacia.pensoft.net\/article\/185464\">https:\/\/pharmacia.pensoft.net\/article\/185464<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[143] 10-K &#8211; SEC.gov (source nr: 143)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1876588\/000095017025027757\/zimv-20241231.htm\">https:\/\/www.sec.gov\/Archives\/edgar\/data\/1876588\/000095017025027757\/zimv-20241231.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[146] Form 10-K for Globus Medical INC filed 02\/24\/2026 (source nr: 146)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.investors.globusmedical.com\/static-files\/e624db10-ac2e-461a-af60-a7bde1286e75\">https:\/\/www.investors.globusmedical.com\/static-files\/e624db10-ac2e-461a-af60-a7bde1286e75<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[147, 306, 351] mdln-20251231 &#8211; SEC.gov (source nr: 147, 306, 351)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/2046386\/000204638626000009\/mdln-20251231.htm\">https:\/\/www.sec.gov\/Archives\/edgar\/data\/2046386\/000204638626000009\/mdln-20251231.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[148] Form 10-K for Labcorp Holdings INC filed 02\/25\/ 2025 (source nr: 148)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/ir.labcorp.com\/static-files\/8488f4b1-35f1-49bd-9fc0-0aaf0a744944\">https:\/\/ir.labcorp.com\/static-files\/8488f4b1-35f1-49bd-9fc0-0aaf0a744944<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[149, 355] Form 10-K for Enovis Corp filed 02\/26\/ 2025 (source nr: 149, 355)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/ir.enovis.com\/static-files\/299690a7-c395-48df-b889-285fb46a34fa\">https:\/\/ir.enovis.com\/static-files\/299690a7-c395-48df-b889-285fb46a34fa<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[150, 354] Form 10-K for Abbott Laboratories filed 02\/21\/ 2025 &#8211; Investors (source nr: 150, 354)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.abbottinvestor.com\/static-files\/2b75fde0-1c65-4b0e-b0b6-ea78d31cb652\">https:\/\/www.abbottinvestor.com\/static-files\/2b75fde0-1c65-4b0e-b0b6-ea78d31cb652<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[151] Medical Device Regulatory Updates: Key Legal Developments for &#8230; (source nr: 151)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.huatengbiotech.com\/news\/Medical-Device-Regulatory-Updates-Key-Legal-Developments-for-2025.html\">https:\/\/www.huatengbiotech.com\/news\/Medical-Device-Regulatory-Updates-Key-Legal-Developments-for-2025.html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[153] AtriCure 12\/31\/ 2025 Form 10-K (source nr: 153)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/ir.atricure.com\/static-files\/0eb5a8c2-0d2c-453f-8ad1-d84fe6c92484\">https:\/\/ir.atricure.com\/static-files\/0eb5a8c2-0d2c-453f-8ad1-d84fe6c92484<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[154] dih holding us, inc. &#8211; SEC.gov (source nr: 154)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1883788\/000149315225018682\/form10-k.htm\">https:\/\/www.sec.gov\/Archives\/edgar\/data\/1883788\/000149315225018682\/form10-k.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[157] Form 10-K for Delcath Systems INC filed 03\/06\/2025 (source nr: 157)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investors.delcath.com\/static-files\/9d81a252-1cf2-4625-b0b9-ec30bbac160d\">https:\/\/investors.delcath.com\/static-files\/9d81a252-1cf2-4625-b0b9-ec30bbac160d<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[158] SEC Filing &#8211; Investor Relations &#8211; GRAIL, Inc. (source nr: 158)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investors.grail.com\/node\/6871\/html\">https:\/\/investors.grail.com\/node\/6871\/html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[159] securities and exchange commission &#8211; SEC.gov (source nr: 159)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1933567\/000149315223025136\/forms-1a.htm\">https:\/\/www.sec.gov\/Archives\/edgar\/data\/1933567\/000149315223025136\/forms-1a.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[160] Form 10-K for Sibone INC filed 02\/25\/2025 (source nr: 160)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investor.si-bone.com\/static-files\/8315c55b-7667-41c1-8407-e36634eb0860\">https:\/\/investor.si-bone.com\/static-files\/8315c55b-7667-41c1-8407-e36634eb0860<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[162] Form 10-K for Artivion INC filed 02\/23\/2024 (source nr: 162)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investors.artivion.com\/static-files\/d2195b4b-0f17-429c-8228-61c35846d74c\">https:\/\/investors.artivion.com\/static-files\/d2195b4b-0f17-429c-8228-61c35846d74c<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[164, 359] Form 10-K for Intuitive Surgical INC filed 01\/31\/2024 (source nr: 164, 359)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/isrg.intuitive.com\/static-files\/e135b0a9-6bf2-4b2c-9ff8-98416604c173\">https:\/\/isrg.intuitive.com\/static-files\/e135b0a9-6bf2-4b2c-9ff8-98416604c173<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[165] Mallinckrodt plc &#8211; Investor Relations (source nr: 165)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/mallinckrodt.gcs-web.com\/static-files\/156a8da4-a71a-4347-89ca-c2a22deb89fe\">https:\/\/mallinckrodt.gcs-web.com\/static-files\/156a8da4-a71a-4347-89ca-c2a22deb89fe<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[166] Apps in healthcare and medical research; European legislation and &#8230; (source nr: 166)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1386505623001594\">https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1386505623001594<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[167] united states securities and exchange commission &#8211; form 10-k (source nr: 167)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investors.transmedics.com\/static-files\/d1f86677-ffc5-4287-b6d5-7f1c5d97a7ff\">https:\/\/investors.transmedics.com\/static-files\/d1f86677-ffc5-4287-b6d5-7f1c5d97a7ff<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[168] Form 10-K for Procept Biorobotics Corp filed 02\/27\/2025 (source nr: 168)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/ir.procept-biorobotics.com\/static-files\/d2e5e853-eb75-40bb-8158-347e4f261ad6\">https:\/\/ir.procept-biorobotics.com\/static-files\/d2e5e853-eb75-40bb-8158-347e4f261ad6<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[169, 308] Form 10-K for Tela BIO INC filed 03\/21\/2025 (source nr: 169, 308)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/ir.telabio.com\/static-files\/49e025ab-5e3c-483b-b78c-83ddbfd691a4\">https:\/\/ir.telabio.com\/static-files\/49e025ab-5e3c-483b-b78c-83ddbfd691a4<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[170] EDGAR PDF &#8211; Profound Medical (source nr: 170)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/profoundmedical.com\/wp-content\/uploads\/2025\/05\/Profound-Medical-Corp_10-K_bannerless-FINAL.pdf\">https:\/\/profoundmedical.com\/wp-content\/uploads\/2025\/05\/Profound-Medical-Corp_10-K_bannerless-FINAL.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[171] Form 10-K for Angiodynamics INC filed 07\/25\/2024 &#8211; Investors (source nr: 171)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investors.angiodynamics.com\/static-files\/0e82b084-f97a-4087-9087-c71de2de7450\">https:\/\/investors.angiodynamics.com\/static-files\/0e82b084-f97a-4087-9087-c71de2de7450<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[172] LivaNova PLC (source nr: 172)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investor.livanova.com\/static-files\/95c4dd9c-116d-4e54-8d86-5f7bc4d7f56c\">https:\/\/investor.livanova.com\/static-files\/95c4dd9c-116d-4e54-8d86-5f7bc4d7f56c<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[174] Transformation of European Medical Device Regulation &#8211; Pharmacia (source nr: 174)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/pharmacia.pensoft.net\/article\/175312\">https:\/\/pharmacia.pensoft.net\/article\/175312<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[175] The Challenges for Manufacturers of the Increased Clinical &#8230; &#8211; PMC (source nr: 175)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10276779\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10276779<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[176] Clinical investigations for medical devices &#8211; GOV.UK (source nr: 176)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.gov.uk\/guidance\/notify-mhra-about-a-clinical-investigation-for-a-medical-device\">https:\/\/www.gov.uk\/guidance\/notify-mhra-about-a-clinical-investigation-for-a-medical-device<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[177] medicaldeviceslegal | Medical devices legal and regulatory blog (source nr: 177)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/medicaldeviceslegal.com\/\">https:\/\/medicaldeviceslegal.com\/<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[178] EU General Product Safety Regulation (GPSR) \u2014 Compliance Guide (source nr: 178)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/traceable.digital\/regulatory\/gpsr\">https:\/\/traceable.digital\/regulatory\/gpsr<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[179] EU Digital Omnibus: What the Proposed Reforms Mean for Pharma &#8230; (source nr: 179)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.arnoldporter.com\/en\/perspectives\/advisories\/2026\/02\/eu-digital-omnibus-what-the-proposed-reforms-mean-for-pharma-and-medtech\">https:\/\/www.arnoldporter.com\/en\/perspectives\/advisories\/2026\/02\/eu-digital-omnibus-what-the-proposed-reforms-mean-for-pharma-and-medtech<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[180] The European AI liability directives \u2013 Critique of a half-hearted &#8230; (source nr: 180)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S026736492300081X\">https:\/\/www.sciencedirect.com\/science\/article\/pii\/S026736492300081X<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[181] Single Market Barriers Overview &#8211; EuroCommerce (source nr: 181)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.eurocommerce.eu\/2024-05-single-market-barriers-overview-2\">https:\/\/www.eurocommerce.eu\/2024-05-single-market-barriers-overview-2<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[182] Pre-authorisation guidance | European Medicines Agency (EMA) (source nr: 182)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/marketing-authorisation\/pre-authorisation-guidance\">https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/marketing-authorisation\/pre-authorisation-guidance<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[183, 235, 325] COM(2025) 1023 final &#8211; EUR-Lex (source nr: 183, 235, 325)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=CELEX%3A52025PC1023\">https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=CELEX%3A52025PC1023<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[185, 342] European Union &#8211; WTO Trade Concerns (source nr: 185, 342)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/tradeconcerns.wto.org\/en\/stcs\/details?imsId=594&amp;domainId=TBT\">https:\/\/tradeconcerns.wto.org\/en\/stcs\/details?imsId=594&amp;domainId=TBT<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[186] Say goodbye to my little FRAND1: is the withdrawal of the European &#8230; (source nr: 186)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/academic.oup.com\/jiplp\/article\/20\/8\/523\/8221809\">https:\/\/academic.oup.com\/jiplp\/article\/20\/8\/523\/8221809<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[187] EDAP TMS SA_December 31, 2024 &#8211; SEC.gov (source nr: 187)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1041934\/000155837025003828\/edap-20241231x20f.htm\">https:\/\/www.sec.gov\/Archives\/edgar\/data\/1041934\/000155837025003828\/edap-20241231x20f.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[188] Effects of the Cyber Resilience Act (CRA) on Industrial Equipment &#8230; (source nr: 188)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/arxiv.org\/html\/2505.14325v2\">https:\/\/arxiv.org\/html\/2505.14325v2<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[189] Regulation 2024 \/1689 of the Eur. Parl. &amp; Council of June 13, 2024 &#8230; (source nr: 189)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.cambridge.org\/core\/journals\/international-legal-materials\/article\/regulation-20241689-of-the-eur-parl-council-of-june-13-2024-eu-artificial-intelligence-act\/64F1F6734F8C66CA3EEA149C9759194E\">https:\/\/www.cambridge.org\/core\/journals\/international-legal-materials\/article\/regulation-20241689-of-the-eur-parl-council-of-june-13-2024-eu-artificial-intelligence-act\/64F1F6734F8C66CA3EEA149C9759194E<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[190] Fostering convergence in SME sustainability reporting &#8211; OECD (source nr: 190)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/one.oecd.org\/document\/CFE\/SME(2024)13\/FINAL\/en\/pdf\">https:\/\/one.oecd.org\/document\/CFE\/SME(2024)13\/FINAL\/en\/pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[191] Orphan Medical Devices and Pediatric Cardiology &#8211; PMC (source nr: 191)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9579647\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9579647<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[192] Global Market Access Regulatory News Update &#8211; UL Solutions (source nr: 192)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.ul.com\/resources\/global-market-access-regulatory-news-update\">https:\/\/www.ul.com\/resources\/global-market-access-regulatory-news-update<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[193] European Medical Device Regulations MDR &amp; IVDR &#8211; Lean Entries (source nr: 193)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.leanentries.com\/wp-content\/uploads\/european-medical-device-regulations-mdr-ivdr-a-guide-to-market.pdf\">https:\/\/www.leanentries.com\/wp-content\/uploads\/european-medical-device-regulations-mdr-ivdr-a-guide-to-market.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[194] multiclass Text Classification &#8211; Kaggle (source nr: 194)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.kaggle.com\/code\/ragisaikiranreddy\/multiclass-text-classification\">https:\/\/www.kaggle.com\/code\/ragisaikiranreddy\/multiclass-text-classification<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[195, 237] Manufacturers MD &#8211; Public Health &#8211; European Commission (source nr: 195, 237)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/medical-devices-topics-interest\/reprocessing-devices\/manufacturers-md_en\">https:\/\/health.ec.europa.eu\/medical-devices-topics-interest\/reprocessing-devices\/manufacturers-md_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[196] EU- MDR Affected CE Marking : Complete Guide for Medical Device Manufacturers (source nr: 196)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/operonstrategist.com\/eu-mdr-affected-ce-marking\">https:\/\/operonstrategist.com\/eu-mdr-affected-ce-marking<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[197] CE marking a new medical device with the MDR or IVDR: will it take one year? &#8211; Software in Medical Devices, by MD101 Consulting (source nr: 197)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/blog.cm-dm.com\/post\/2020\/11\/20\/CE-marking-a-new-medical-device-with-the-MDR-or-IVDR:-will-it-take-one-year\">https:\/\/blog.cm-dm.com\/post\/2020\/11\/20\/CE-marking-a-new-medical-device-with-the-MDR-or-IVDR:-will-it-take-one-year<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[198] CE Marking for Medical Devices: EU MDR Requirements, Process, and Assessment | MedDeviceGuide (source nr: 198)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/meddeviceguide.com\/blog\/ce-marking-medical-devices-guide\">https:\/\/meddeviceguide.com\/blog\/ce-marking-medical-devices-guide<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[199, 347] The authorities are not your friend anymore; and neither are notified bodies | medicaldeviceslegal (source nr: 199, 347)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/medicaldeviceslegal.com\/2016\/12\/15\/the-authorities-are-not-your-friend-anymore-and-neither-are-notified-bodies\">https:\/\/medicaldeviceslegal.com\/2016\/12\/15\/the-authorities-are-not-your-friend-anymore-and-neither-are-notified-bodies<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[200, 316] Notified Body Support for Medical Device Compliance | Emergo by UL (source nr: 200, 316)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.emergobyul.com\/services\/notified-body-support-medical-device-compliance\">https:\/\/www.emergobyul.com\/services\/notified-body-support-medical-device-compliance<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[201] Medical Device Registration in Europe in 2026: Guide (source nr: 201)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/zamann-pharma.com\/2026\/08\/04\/medical-device-registration-in-europe-in-year-eu-mdr-ce-marking-eudamed-and-market-access-guide\">https:\/\/zamann-pharma.com\/2026\/08\/04\/medical-device-registration-in-europe-in-year-eu-mdr-ce-marking-eudamed-and-market-access-guide<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[203] Guide to CE Marking for Medical Devices under EU MDR (2025) (source nr: 203)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/decomplix.com\/medical-device-ce-marking-guide\">https:\/\/decomplix.com\/medical-device-ce-marking-guide<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[204] CE Marking for Medical Devices under MDR : A Complete Guide (source nr: 204)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.qualityze.com\/blogs\/ce-marking-medical-devices-mdr\">https:\/\/www.qualityze.com\/blogs\/ce-marking-medical-devices-mdr<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[205] European CE Marking Strategy for Medical Devices | Emergo by UL (source nr: 205)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.emergobyul.com\/services\/european-ce-marking-strategy-medical-devices\">https:\/\/www.emergobyul.com\/services\/european-ce-marking-strategy-medical-devices<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[206] How to Obtain CE Marking Under the MDR | RQM+ (source nr: 206)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.rqmplus.com\/blog\/ce-marking-under-the-mdr\">https:\/\/www.rqmplus.com\/blog\/ce-marking-under-the-mdr<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[207, 336] EU MDR Notified Bodies and Conformity Assessment Guide | MedDeviceGuide (source nr: 207, 336)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/meddeviceguide.com\/blog\/eu-mdr-notified-body-conformity-assessment-guide\">https:\/\/meddeviceguide.com\/blog\/eu-mdr-notified-body-conformity-assessment-guide<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[209] Getting a Handle on EU MDR (source nr: 209)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.mddionline.com\/medical-device-regulations\/getting-a-handle-on-eu-mdr\">https:\/\/www.mddionline.com\/medical-device-regulations\/getting-a-handle-on-eu-mdr<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[210] CE Marking for Medical Devices under EU MDR 2017\/745 (source nr: 210)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/morulaa.com\/eu-mdr-2017-745-medical-device-regulation-ce-marking\">https:\/\/morulaa.com\/eu-mdr-2017-745-medical-device-regulation-ce-marking<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[211] EU MDR CE Marking Certification Process | Emergo by UL (source nr: 211)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.emergobyul.com\/resources\/european-medical-devices-regulation-mdr-ce-marking-regulatory-process\">https:\/\/www.emergobyul.com\/resources\/european-medical-devices-regulation-mdr-ce-marking-regulatory-process<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[213] EU MDR CE Marking Approval for Medical Devices (source nr: 213)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.pureglobal.com\/markets\/european-union\/eu-mdr-consulting\/eu-mdr-ce-marking-approval-for-medical-devices\">https:\/\/www.pureglobal.com\/markets\/european-union\/eu-mdr-consulting\/eu-mdr-ce-marking-approval-for-medical-devices<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[214] EU &#8216;s General Product Safety Regulation (GPSR): A New Era of &#8230; (source nr: 214)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/trade.ec.europa.eu\/access-to-markets\/en\/news\/eus-general-product-safety-regulation-gpsr-new-era-consumer-protection\">https:\/\/trade.ec.europa.eu\/access-to-markets\/en\/news\/eus-general-product-safety-regulation-gpsr-new-era-consumer-protection<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[215] Medical Devices &#8211; New regulations &#8211; Public Health &#8211; European Commission (source nr: 215)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/medical-devices-new-regulations_en\">https:\/\/health.ec.europa.eu\/medical-devices-new-regulations_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[216] Medical Devices Medical Device Coordination Group Document MDCG 2024 -1 (source nr: 216)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/document\/download\/dbd0d748-d646-4274-afaa-399952809389_en?filename=mdcg_2024-1_en.pdf\">https:\/\/health.ec.europa.eu\/document\/download\/dbd0d748-d646-4274-afaa-399952809389_en?filename=mdcg_2024-1_en.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[217] EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY (source nr: 217)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/document\/download\/ff5716d5-fe77-4f45-b883-fcf3da4acd15_en?filename=md_nbs_fees_en.pdf\">https:\/\/health.ec.europa.eu\/document\/download\/ff5716d5-fe77-4f45-b883-fcf3da4acd15_en?filename=md_nbs_fees_en.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[218] EN EN EUROPEAN COMMISSION Strasbourg, 16.12.2025 COM(2025) 1023 final (source nr: 218)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/document\/download\/25e7ea7c-cab3-40cf-86d9-d11f5e7744d8_en?filename=md_com_2025-1023_act_en.pdf\">https:\/\/health.ec.europa.eu\/document\/download\/25e7ea7c-cab3-40cf-86d9-d11f5e7744d8_en?filename=md_com_2025-1023_act_en.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[219] Medical Devices Medical Device Coordination Group Document MDCG 2023 -3 Rev.2 (source nr: 219)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/document\/download\/af1433fd-ed64-4c53-abc7-612a7f16f976_en?filename=mdcg_2023-3_en.pdf\">https:\/\/health.ec.europa.eu\/document\/download\/af1433fd-ed64-4c53-abc7-612a7f16f976_en?filename=mdcg_2023-3_en.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[220] Overview &#8211; Public Health &#8211; European Commission (source nr: 220)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/ec.europa.eu\/health\/md_newregulations\/overview_en\">https:\/\/ec.europa.eu\/health\/md_newregulations\/overview_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[221] Questions and Answers: Commission proposes an extension of the transitional periods for the application of the Medical Devices Regulation (source nr: 221)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/qanda_23_24\">https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/qanda_23_24<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[222] Medical Devices &#8211; Sector &#8211; Public Health &#8211; European Commission (source nr: 222)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/medical-devices-sector_en\">https:\/\/health.ec.europa.eu\/medical-devices-sector_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[223] Update of the guidelines on the benefit-risk assessment of the &#8230; (source nr: 223)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/document\/download\/831f9b60-88de-4197-858f-d001c5b0cc26_en\">https:\/\/health.ec.europa.eu\/document\/download\/831f9b60-88de-4197-858f-d001c5b0cc26_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[224] Liability for defective products (source nr: 224)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/single-market-economy.ec.europa.eu\/single-market\/goods\/free-movement-sectors\/liability-defective-products_en\">https:\/\/single-market-economy.ec.europa.eu\/single-market\/goods\/free-movement-sectors\/liability-defective-products_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[225] Regulation ( EU ) 2024 \/1689 of the European Parliament &#8230; &#8211; EUR-Lex (source nr: 225)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF?uri=OJ%3AL_202401689\">https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF?uri=OJ%3AL_202401689<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[227, 362] biotech_reg-com2025-1022_act_en.pdf (source nr: 227, 362)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/document\/download\/ec1475b7-e3f9-409e-b927-fc7e69306a8c_en?filename=biotech_reg-com2025-1022_act_en.pdf\">https:\/\/health.ec.europa.eu\/document\/download\/ec1475b7-e3f9-409e-b927-fc7e69306a8c_en?filename=biotech_reg-com2025-1022_act_en.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[228] AI Act | Shaping Europe&#8217;s digital future (source nr: 228)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/digital-strategy.ec.europa.eu\/en\/policies\/regulatory-framework-ai\">https:\/\/digital-strategy.ec.europa.eu\/en\/policies\/regulatory-framework-ai<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[229] Waste from Electrical and Electronic Equipment (WEEE) &#8211; Environment (source nr: 229)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/environment.ec.europa.eu\/topics\/waste-and-recycling\/waste-electrical-and-electronic-equipment-weee_en\">https:\/\/environment.ec.europa.eu\/topics\/waste-and-recycling\/waste-electrical-and-electronic-equipment-weee_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[230] EUROPEAN COMMISSION Brussels, 15.11. 2024 C &#8230; &#8211; Public Health (source nr: 230)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/document\/download\/4fb8f72b-eac7-484f-9bab-03c945f59032_en?filename=c2024_7871_annex_en.pdf&amp;prefLang=pl\">https:\/\/health.ec.europa.eu\/document\/download\/4fb8f72b-eac7-484f-9bab-03c945f59032_en?filename=c2024_7871_annex_en.pdf&amp;prefLang=pl<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[231, 368] IMMC.SWD%282025%29836%20final.ENG.xhtml &#8230; &#8211; EUR-Lex (source nr: 231, 368)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=CELEX%3A52025SC0836\">https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=CELEX%3A52025SC0836<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[232] Transition Timelines from the Directives to the Regulations (source nr: 232)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/system\/files\/2020-07\/md_infographic-timeline_en_0.pdf\">https:\/\/health.ec.europa.eu\/system\/files\/2020-07\/md_infographic-timeline_en_0.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[233] EXTENSION OF THE MDR TRANSITIONAL PERIOD AND &#8230; (source nr: 233)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/document\/download\/592008f6-3456-4afb-a13a-733a87da1b00_en?filename=\">https:\/\/health.ec.europa.eu\/document\/download\/592008f6-3456-4afb-a13a-733a87da1b00_en?filename=<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[234] Maquinaria y productos t\u00e9cnicos &#8211; European Commission&#8217;s trade (source nr: 234)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/trade.ec.europa.eu\/access-to-markets\/es\/content\/maquinaria-y-productos-tecnicos\">https:\/\/trade.ec.europa.eu\/access-to-markets\/es\/content\/maquinaria-y-productos-tecnicos<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[236] IMMC.COM( 2023 )10 final.ENG.xhtml.1_EN_ACT_part1_v3.docx (source nr: 236)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=CELEX%3A52023PC0010\">https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=CELEX%3A52023PC0010<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[238] 2017\/745 &#8211; EN &#8211; Medical Device Regulation &#8211; EUR-Lex &#8211; Europa. eu (source nr: 238)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN-IT\/TXT?uri=CELEX%3A32017R0745\">https:\/\/eur-lex.europa.eu\/legal-content\/EN-IT\/TXT?uri=CELEX%3A32017R0745<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[239] Directives &#8211; Public Health &#8211; European Commission &#8211; Europa. eu (source nr: 239)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/medical-devices-sector\/directives_en\">https:\/\/health.ec.europa.eu\/medical-devices-sector\/directives_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[240] Regulation ( EU ) 2023 \/ of the European Parliament and of &#8230; &#8211; EUR-Lex (source nr: 240)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF?uri=CELEX%3A32023R1542\">https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF?uri=CELEX%3A32023R1542<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[241] Brussels, 12.9.2025 SWD(2025) 268 final COMMISSION STAFF &#8230; (source nr: 241)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF?uri=CELEX%3A52025SC0268\">https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF?uri=CELEX%3A52025SC0268<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[242] Achieving resilience through&#8230; &#8211; Open Research Europe &#8211; Europa. eu (source nr: 242)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/open-research-europe.ec.europa.eu\/articles\/6-281\">https:\/\/open-research-europe.ec.europa.eu\/articles\/6-281<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[243] Animals in science &#8211; Environment &#8211; European Commission (source nr: 243)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/environment.ec.europa.eu\/topics\/chemicals\/animals-science_en\">https:\/\/environment.ec.europa.eu\/topics\/chemicals\/animals-science_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[244] Medical devices &#8211; Internal Market, Industry, Entrepreneurship and SMEs (source nr: 244)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/single-market-economy.ec.europa.eu\/single-market\/goods\/european-standards\/harmonised-standards\/medical-devices_en\">https:\/\/single-market-economy.ec.europa.eu\/single-market\/goods\/european-standards\/harmonised-standards\/medical-devices_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[246] Have your say &#8211; Public Consultations and Feedback (source nr: 246)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/ec.europa.eu\/info\/law\/better-regulation\">https:\/\/ec.europa.eu\/info\/law\/better-regulation<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[247] Getting ready for the new regulations &#8211; Public Health &#8211; European Commission (source nr: 247)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/medical-devices-new-regulations\/getting-ready-new-regulations_en\">https:\/\/health.ec.europa.eu\/medical-devices-new-regulations\/getting-ready-new-regulations_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[248] IMMC.COM( 2024 )560 final.ENG.xhtml.1_EN_ACT_part1_v3.docx (source nr: 248)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=CELEX%3A52024DC0560\">https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=CELEX%3A52024DC0560<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[249] Gender-based violence and harassment in the world of work (source nr: 249)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/open-research-europe.ec.europa.eu\/articles\/6-122\/pdf\">https:\/\/open-research-europe.ec.europa.eu\/articles\/6-122\/pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[250] MDR IVDR amendment_Jan. 2023 (source nr: 250)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/system\/files\/2023-01\/mdr_proposal.pdf\">https:\/\/health.ec.europa.eu\/system\/files\/2023-01\/mdr_proposal.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[251] Official Journal C 75\/28 F &#8211; EUR-Lex (source nr: 251)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=OJ%3AC%3A2023%3A075%3AFULL\">https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=OJ%3AC%3A2023%3A075%3AFULL<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[252] Manufacturers of devices without an intended medical purpose &#8211; Public Health (source nr: 252)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/medical-devices-topics-interest\/reprocessing-devices\/manufacturers-devices-without-intended-medical-purpose_en\">https:\/\/health.ec.europa.eu\/medical-devices-topics-interest\/reprocessing-devices\/manufacturers-devices-without-intended-medical-purpose_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[255] Philips &#8211; Medical Product Outsourcing (source nr: 255)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.mpo-mag.com\/top-company-profile\/philips\">https:\/\/www.mpo-mag.com\/top-company-profile\/philips<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[256] Recalled Philips Ventilators, BiPAP Machines, and CPAP Machines | FDA (source nr: 256)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.fda.gov\/medical-devices\/respiratory-devices\/recalled-philips-ventilators-bipap-machines-and-cpap-machines\">https:\/\/www.fda.gov\/medical-devices\/respiratory-devices\/recalled-philips-ventilators-bipap-machines-and-cpap-machines<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[257] How Philips &#8216; significant respiratory devices recall unfolded (source nr: 257)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.massdevice.com\/how-philips-significant-respiratory-devices-recall-unfolded\">https:\/\/www.massdevice.com\/how-philips-significant-respiratory-devices-recall-unfolded<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[258] Philips CPAP Recall : Updates &amp; FDA Safety News (source nr: 258)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.drugwatch.com\/philips-cpap\/recall\">https:\/\/www.drugwatch.com\/philips-cpap\/recall<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[260] AASM guidance in response to Philips recall of PAP devices (source nr: 260)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/aasm.org\/clinical-resources\/guidance-philips-recall-pap-devices\">https:\/\/aasm.org\/clinical-resources\/guidance-philips-recall-pap-devices<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[261] Innovation at the heart of Europe&#8217;s medtech sector I With more than &#8230; (source nr: 261)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.facebook.com\/MedTechEurope\/posts\/innovation-at-the-heart-of-europes-medtech-sector-i-with-more-than-2-million-med\/1493802079421753\">https:\/\/www.facebook.com\/MedTechEurope\/posts\/innovation-at-the-heart-of-europes-medtech-sector-i-with-more-than-2-million-med\/1493802079421753<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[262] Philips Respironics provides update on filed MDRs in connection with the voluntary recall notification\/field safety notice* for specific CPAP , BiPAP and mechanical ventilator devices &#8211; News | Philips (source nr: 262)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.philips.com\/a-w\/about\/news\/archive\/standard\/news\/press\/2022\/20220524-philips-respironics-provides-update-on-filed-mdrs-in-connection-with-the-voluntary-recall-notification-field-safety-notice.html\">https:\/\/www.philips.com\/a-w\/about\/news\/archive\/standard\/news\/press\/2022\/20220524-philips-respironics-provides-update-on-filed-mdrs-in-connection-with-the-voluntary-recall-notification-field-safety-notice.html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[263] Philips CPAP Recall Lawsuit | Philips Respironics CPAP Cancer &amp; Injury Claims &#8211; Credible Law (source nr: 263)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/crediblelaw.com\/philips-cpap-recall-lawsuit\">https:\/\/crediblelaw.com\/philips-cpap-recall-lawsuit<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[264] Medical Device Recall Information &#8211; Philips Respironics Sleep and Respiratory Care devices (source nr: 264)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.usa.philips.com\/healthcare\/e\/sleep\/communications\/src-update\">https:\/\/www.usa.philips.com\/healthcare\/e\/sleep\/communications\/src-update<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[265] insp-20241231 &#8211; SEC.gov (source nr: 265)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1609550\/000160955025000011\/insp-20241231.htm\">https:\/\/www.sec.gov\/Archives\/edgar\/data\/1609550\/000160955025000011\/insp-20241231.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[267] queryResult &#8211; FDA (source nr: 267)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.fda.gov\/media\/183958\/download\">https:\/\/www.fda.gov\/media\/183958\/download<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[268] FDA Activities Related to Recalled Philips Ventilators, BiPAP Machines, and CPAP Machines | FDA (source nr: 268)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.fda.gov\/medical-devices\/recalled-philips-ventilators-bipap-machines-and-cpap-machines\/fda-activities-related-recalled-philips-ventilators-bipap-machines-and-cpap-machines\">https:\/\/www.fda.gov\/medical-devices\/recalled-philips-ventilators-bipap-machines-and-cpap-machines\/fda-activities-related-recalled-philips-ventilators-bipap-machines-and-cpap-machines<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[269] Recommendations for Recalled Philips Ventilators, BiPAP Machines, and CPAP Machines | FDA (source nr: 269)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.fda.gov\/medical-devices\/recalled-philips-ventilators-bipap-machines-and-cpap-machines\/recommendations-recalled-philips-ventilators-bipap-machines-and-cpap-machines\">https:\/\/www.fda.gov\/medical-devices\/recalled-philips-ventilators-bipap-machines-and-cpap-machines\/recommendations-recalled-philips-ventilators-bipap-machines-and-cpap-machines<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[270] Over the Counter (OTC) vs. Prescription (RX) Medical Devices, Pt. 1 (source nr: 270)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.greenlight.guru\/blog\/over-the-counter-otc-vs.-prescription-rx-medical-devices-pt.-1\">https:\/\/www.greenlight.guru\/blog\/over-the-counter-otc-vs.-prescription-rx-medical-devices-pt.-1<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[271] CPAP &amp; BiPAP Machine CDSCO Approval | MD-15 Import License &#8230; (source nr: 271)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/medicaldeviceregistration.com\/blog\/cpap-bipap-machine-cdsco-approval-md15-import-license\">https:\/\/medicaldeviceregistration.com\/blog\/cpap-bipap-machine-cdsco-approval-md15-import-license<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[272] Medical device advisories or recalls are fortunately rare, but how do &#8230; (source nr: 272)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.facebook.com\/uvahealth\/posts\/medical-device-advisories-or-recalls-are-fortunately-rare-but-how-do-you-find-ou\/1362186159280348\">https:\/\/www.facebook.com\/uvahealth\/posts\/medical-device-advisories-or-recalls-are-fortunately-rare-but-how-do-you-find-ou\/1362186159280348<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[273] Frequently Asked Questions on Philips Recall of PAP Devices &#8211; AARC (source nr: 273)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.aarc.org\/advocacy\/federal-advocacy\/fda-updates-mandates\/frequently-asked-questions-on-philips-recall-of-pap-devices\">https:\/\/www.aarc.org\/advocacy\/federal-advocacy\/fda-updates-mandates\/frequently-asked-questions-on-philips-recall-of-pap-devices<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[274] Post-Market Surveillance for Medical Devices: The Complete Guide (source nr: 274)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/meddeviceguide.com\/blog\/post-market-surveillance-guide\">https:\/\/meddeviceguide.com\/blog\/post-market-surveillance-guide<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[275] International Markets and Developments for Medical Devices (source nr: 275)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.researchgate.net\/publication\/397168246_International_Markets_and_Developments_for_Medical_Devices\">https:\/\/www.researchgate.net\/publication\/397168246_International_Markets_and_Developments_for_Medical_Devices<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[276] CPAP Recalls: What You Need to Know (source nr: 276)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sleepfoundation.org\/cpap\/cpap-recalls\">https:\/\/www.sleepfoundation.org\/cpap\/cpap-recalls<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[277] Sleep Apnea Devices Market Size, Share &amp; Growth Drivers 2031 (source nr: 277)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.mordorintelligence.com\/industry-reports\/global-sleep-apnea-devices-market-industry\">https:\/\/www.mordorintelligence.com\/industry-reports\/global-sleep-apnea-devices-market-industry<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[278] Philips &#8216; US sales of sleep apnea devices face years-long halt after FDA deal | Reuters (source nr: 278)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/philips-reaches-compliance-agreement-with-fda-over-ventilator-recall-2024-01-29\">https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/philips-reaches-compliance-agreement-with-fda-over-ventilator-recall-2024-01-29<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[279] Philips CPAP , Respironics Recall April 2025 &#8211; Select Justice (source nr: 279)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.selectjustice.com\/philips-cpap-recall\">https:\/\/www.selectjustice.com\/philips-cpap-recall<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[280] Problems Reported with Recalled Philips Ventilators, BiPAP Machines, and CPAP Machines | FDA (source nr: 280)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.fda.gov\/medical-devices\/recalled-philips-ventilators-bipap-machines-and-cpap-machines\/problems-reported-recalled-philips-ventilators-bipap-machines-and-cpap-machines\">https:\/\/www.fda.gov\/medical-devices\/recalled-philips-ventilators-bipap-machines-and-cpap-machines\/problems-reported-recalled-philips-ventilators-bipap-machines-and-cpap-machines<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[281] Securing Medical Supply Chains in a Post-Pandemic World &#8211; OECD (source nr: 281)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.oecd.org\/en\/publications\/2024\/02\/securing-medical-supply-chains-in-a-post-pandemic-world_3c8cef7c\/full-report\/component-4.html\">https:\/\/www.oecd.org\/en\/publications\/2024\/02\/securing-medical-supply-chains-in-a-post-pandemic-world_3c8cef7c\/full-report\/component-4.html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[282] tm2111148-6_f1 &#8211; none &#8211; 38.5856613s &#8211; SEC.gov (source nr: 282)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1857190\/000110465921079516\/tm2111148-6_f1.htm\">https:\/\/www.sec.gov\/Archives\/edgar\/data\/1857190\/000110465921079516\/tm2111148-6_f1.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[283] SAN &#8211; National Services Scotland (source nr: 283)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.nss.nhs.scot\/media\/5136\/nss-iric-safety-warning-database-web-access-updated-03-apr-24.xlsx\">https:\/\/www.nss.nhs.scot\/media\/5136\/nss-iric-safety-warning-database-web-access-updated-03-apr-24.xlsx<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[284] Philips recall action for CPAP , Bi-Level PAP devices and mechanical ventilators | Therapeutic Goods Administration (TGA) (source nr: 284)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.tga.gov.au\/safety\/recalls-and-other-market-actions\/market-actions\/philips-recall-action-cpap-bi-level-pap-devices-and-mechanical-ventilators\">https:\/\/www.tga.gov.au\/safety\/recalls-and-other-market-actions\/market-actions\/philips-recall-action-cpap-bi-level-pap-devices-and-mechanical-ventilators<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[285] Philips Respironics CPAP , BIPAP, And Ventilator Recall &#8211; Part 2 &#8211; QualityDME (source nr: 285)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/qualitydme.com\/philips-respironics-cpap-bipap-and-ventilator-recall-part-2\">https:\/\/qualitydme.com\/philips-respironics-cpap-bipap-and-ventilator-recall-part-2<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[286] &#8211; DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES &#8230; (source nr: 286)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.govinfo.gov\/content\/pkg\/CHRG-109shrg59104229\/html\/CHRG-109shrg59104229.htm\">https:\/\/www.govinfo.gov\/content\/pkg\/CHRG-109shrg59104229\/html\/CHRG-109shrg59104229.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[287] 10-K: Annual report pursuant to Section 13 and 15(d) (source nr: 287)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investor.resmed.com\/sec-filings\/content\/0000943819-24-000013\/rmd-20240630.htm\">https:\/\/investor.resmed.com\/sec-filings\/content\/0000943819-24-000013\/rmd-20240630.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[288] Respironics field action information for Investor Relations | Philips (source nr: 288)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.philips.com\/a-w\/about\/investor-relations\/recall-sleep-and-respiratory.html\">https:\/\/www.philips.com\/a-w\/about\/investor-relations\/recall-sleep-and-respiratory.html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[289] June 2021 sleep and respiratory recall | Philips | Sleep and Respiratory Care (source nr: 289)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.usa.philips.com\/healthcare\/e\/sleep\/communications\/src-update\/information-for-patients-and-caregivers\">https:\/\/www.usa.philips.com\/healthcare\/e\/sleep\/communications\/src-update\/information-for-patients-and-caregivers<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[290] Koninklijke Philips (NYSE:PHG) Stock Forecast &amp; Analyst Predictions (source nr: 290)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/simplywall.st\/stocks\/us\/healthcare\/nyse-phg\/koninklijke-philips\/future\">https:\/\/simplywall.st\/stocks\/us\/healthcare\/nyse-phg\/koninklijke-philips\/future<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[291] Explained: The voluntary Philips Respironics sleep and respiratory care devices recall | Philips (source nr: 291)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.philips.com\/a-w\/about\/news\/src-recall-explained.html\">https:\/\/www.philips.com\/a-w\/about\/news\/src-recall-explained.html<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[293] Orphan medical devices: addressing the regulatory and access &#8230; (source nr: 293)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12847439\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12847439<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[294] Evaluating the impact of the EU Medical Device Regulation ( MDR &#8230; (source nr: 294)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/journals.plos.org\/plosone\/article?id=10.1371%2Fjournal.pone.0350175\">https:\/\/journals.plos.org\/plosone\/article?id=10.1371%2Fjournal.pone.0350175<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[295] Medical Device Compliance Services | EU MDR , US FDA, UK &#8230; (source nr: 295)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/tecexglobalcompliance.com\/medical-devices-compliance\">https:\/\/tecexglobalcompliance.com\/medical-devices-compliance<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[296] Medical Device M&amp;A and Funding: Due Diligence and Valuation &#8230; (source nr: 296)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/meddeviceguide.com\/blog\/medical-device-mna-funding-investment-guide\">https:\/\/meddeviceguide.com\/blog\/medical-device-mna-funding-investment-guide<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[297] Past Events &#8211; Rocky Mountain Regulatory Affairs Society (source nr: 297)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.rmras.org\/past-events\">https:\/\/www.rmras.org\/past-events<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[298] 1_EN_evaluation_part1_v5.docx &#8211; EUR-Lex (source nr: 298)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=CELEX%3A52025SC1051\">https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/HTML?uri=CELEX%3A52025SC1051<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[299] Medical devices in Bulgaria: Regulatory framework, market &#8230; (source nr: 299)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/pharmacia.pensoft.net\/article\/190081\">https:\/\/pharmacia.pensoft.net\/article\/190081<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[300] FDA Regulation of Medical Devices &#8211; Congress.gov (source nr: 300)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.congress.gov\/crs-product\/R47374\">https:\/\/www.congress.gov\/crs-product\/R47374<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[301] 10-K &#8211; SEC.gov (source nr: 301)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1111485\/000119312526071775\/rxst-20251231.htm\">https:\/\/www.sec.gov\/Archives\/edgar\/data\/1111485\/000119312526071775\/rxst-20251231.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[303] Regulatory landscape of accelerated approval pathways for medical &#8230; (source nr: 303)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.frontiersin.org\/journals\/medical-technology\/articles\/10.3389\/fmedt.2025.1586070\/full\">https:\/\/www.frontiersin.org\/journals\/medical-technology\/articles\/10.3389\/fmedt.2025.1586070\/full<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[304] MDR &amp; ISO 13485 resources \u2014 Articles, documents and references (source nr: 304)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/isofac.fr\/en\/resources\">https:\/\/isofac.fr\/en\/resources<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[307] Radio Equipment Directive (RED) Cybersecurity: Scope, EN 18031 &#8230; (source nr: 307)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.schutzwerk.com\/en\/compliance\/red\">https:\/\/www.schutzwerk.com\/en\/compliance\/red<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[309] Regulatory landscape of accelerated approval pathways for medical &#8230; (source nr: 309)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12119601\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12119601<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[310] Medical Devices; Laboratory Developed Tests &#8211; Federal Register (source nr: 310)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.federalregister.gov\/documents\/2024\/05\/06\/2024-08935\/medical-devices-laboratory-developed-tests\">https:\/\/www.federalregister.gov\/documents\/2024\/05\/06\/2024-08935\/medical-devices-laboratory-developed-tests<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[311] Form 10-K for Tactile Systems Technology INC filed 02\/18\/ 2025 (source nr: 311)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investors.tactilemedical.com\/static-files\/df345219-9fa5-4f56-b493-20ee12316006\">https:\/\/investors.tactilemedical.com\/static-files\/df345219-9fa5-4f56-b493-20ee12316006<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[312] Core Issues That Terminate the MDR Conformity Assessment &#8211; inXso (source nr: 312)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/inxso.pro\/insights\/core-issues-that-terminate-the-mdr-conformity-assessment\">https:\/\/inxso.pro\/insights\/core-issues-that-terminate-the-mdr-conformity-assessment<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[314] EU Notified Bodies for medical devices and IVDs &#8211; Decomplix (source nr: 314)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/decomplix.com\/eu-notified-bodies-for-medical-devices-and-ivds\">https:\/\/decomplix.com\/eu-notified-bodies-for-medical-devices-and-ivds<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[315] European Commission Proposes Simplifying the Rules on EU &#8230; (source nr: 315)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.crowell.com\/en\/insights\/client-alerts\/european-commission-proposes-simplifying-the-rules-on-eu-medical-and-in-vitro-diagnostic-devices\">https:\/\/www.crowell.com\/en\/insights\/client-alerts\/european-commission-proposes-simplifying-the-rules-on-eu-medical-and-in-vitro-diagnostic-devices<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[317] Medical Device Regulation ( MDR ) &#8211; T\u00dcV S\u00dcD (source nr: 317)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.tuvsud.com\/en\/industries\/medical-devices\/medical-device-regulation\">https:\/\/www.tuvsud.com\/en\/industries\/medical-devices\/medical-device-regulation<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[318] EU MDR Implementation: Important Dates And Challenges (source nr: 318)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/compliancearchitects.com\/navigating-eu-mdr-implementation\">https:\/\/compliancearchitects.com\/navigating-eu-mdr-implementation<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[319] Notified bodies have yet to issue MDR certificates for 85% of legacy devices: survey | MedTech Dive (source nr: 319)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.medtechdive.com\/news\/legacy-devices-lack-mdr-certificates-medtech-europe\/627439\">https:\/\/www.medtechdive.com\/news\/legacy-devices-lack-mdr-certificates-medtech-europe\/627439<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[320] Impact of the new European medical device regulation on digital &#8230; (source nr: 320)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.nature.com\/articles\/s41746-026-02812-1\">https:\/\/www.nature.com\/articles\/s41746-026-02812-1<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[321] Notified bodies warn MDR certification bottleneck could lead to medical device shortages | MedTech Dive (source nr: 321)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.medtechdive.com\/news\/notified-bodies-warn-mdr-certification-bottleneck-risks-medical-device-shor\/592521\">https:\/\/www.medtechdive.com\/news\/notified-bodies-warn-mdr-certification-bottleneck-risks-medical-device-shor\/592521<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[322] EU Medical Devices Legislation: What You Need To Know Given &#8230; (source nr: 322)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.arnoldporter.com\/en\/perspectives\/advisories\/2025\/03\/eu-medical-devices-legislation-what-you-need-to-know\">https:\/\/www.arnoldporter.com\/en\/perspectives\/advisories\/2025\/03\/eu-medical-devices-legislation-what-you-need-to-know<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[323] Conformity Assessment of Medical Devices: An Overview from a Notified Body &#8211; PMC (source nr: 323)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12821529\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12821529<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[326] MedTech Europe, from diagnosis to cure &#8211; Homepage (source nr: 326)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.medtecheurope.org\/\">https:\/\/www.medtecheurope.org\/<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[327] Deficiencies of the EU Medical Device Regulation when applying its &#8230; (source nr: 327)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.frontiersin.org\/journals\/medicine\/articles\/10.3389\/fmed.2025.1732399\/full\">https:\/\/www.frontiersin.org\/journals\/medicine\/articles\/10.3389\/fmed.2025.1732399\/full<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[329] NBs survey on certifications and applications ( MDR \/IVDR) 30 &#8230; (source nr: 329)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/document\/download\/59b9d90e-be42-4895-9f6f-bec35138bb0a_en\">https:\/\/health.ec.europa.eu\/document\/download\/59b9d90e-be42-4895-9f6f-bec35138bb0a_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[330] MDR is live. Here are 5 things to know on where the rule stands. | MedTech Dive (source nr: 330)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.medtechdive.com\/news\/mdr-is-live-here-are-5-things-to-know-on-where-the-rule-stands\/600733\">https:\/\/www.medtechdive.com\/news\/mdr-is-live-here-are-5-things-to-know-on-where-the-rule-stands\/600733<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[331] Europe Is Rewriting the Rules on Medical Devices. Here&#8217;s What the Proposed MDR Revision Means for You. (source nr: 331)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/veranex.com\/blog\/what-the-proposed-2025-eu-mdr-revision-means-for-you\">https:\/\/veranex.com\/blog\/what-the-proposed-2025-eu-mdr-revision-means-for-you<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[332] Notified Bodies and Certificates module &#8211; Public Health (source nr: 332)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/medical-devices-eudamed\/notified-bodies-and-certificates-module_en\">https:\/\/health.ec.europa.eu\/medical-devices-eudamed\/notified-bodies-and-certificates-module_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[333] Notified bodies: Tasks and rights &#8211; Johner Institute (source nr: 333)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/blog.johner-institute.com\/tag\/notified-bodies\">https:\/\/blog.johner-institute.com\/tag\/notified-bodies<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[334] Medical Device Regulation ( MDR ) | BSI (source nr: 334)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.bsigroup.com\/en-US\/products-and-services\/medical-devices\/medical-device-regulation-mdr\">https:\/\/www.bsigroup.com\/en-US\/products-and-services\/medical-devices\/medical-device-regulation-mdr<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[335] 6 reasons medtech companies shouldn&#8217;t delay MDR certification (source nr: 335)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.rimsys.io\/blogs\/6-reasons-medtech-should-not-delay-mdr\">https:\/\/www.rimsys.io\/blogs\/6-reasons-medtech-should-not-delay-mdr<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[337] EU MDR Challenges Spark Questions (source nr: 337)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.mddionline.com\/regulatory-quality\/eu-mdr-challenges-spark-questions\">https:\/\/www.mddionline.com\/regulatory-quality\/eu-mdr-challenges-spark-questions<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[338] 2023 Notified Bodies Medical Device Survey Reveals Certification Gap | Exponent (source nr: 338)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.exponent.com\/article\/new-medical-device-survey-reveals-eu-mdr-certification-gap\">https:\/\/www.exponent.com\/article\/new-medical-device-survey-reveals-eu-mdr-certification-gap<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[339] Regulatory | Swiss Medtech (source nr: 339)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.swiss-medtech.ch\/en\/news\/regulatory\">https:\/\/www.swiss-medtech.ch\/en\/news\/regulatory<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[340] Notified bodies for medical devices &#8211; Public Health &#8211; European Commission (source nr: 340)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/health.ec.europa.eu\/medical-devices-topics-interest\/notified-bodies-medical-devices_en\">https:\/\/health.ec.europa.eu\/medical-devices-topics-interest\/notified-bodies-medical-devices_en<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[341] Advancing Regulatory Oversight of Medical Device Trials to Align &#8230; (source nr: 341)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.mdpi.com\/1424-8247\/18\/6\/876\">https:\/\/www.mdpi.com\/1424-8247\/18\/6\/876<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[343] When Will the EU MDR Burden Begin to Ease for Medical Device Manufacturers? (source nr: 343)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.mddionline.com\/medical-device-regulations\/when-will-the-eu-mdr-burden-begin-to-ease-\">https:\/\/www.mddionline.com\/medical-device-regulations\/when-will-the-eu-mdr-burden-begin-to-ease-<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[344] Medical Devices Notified Bodies (source nr: 344)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/repositorio.ulisboa.pt\/bitstreams\/c6cce407-960c-4042-aaf1-9624d6372c2c\/download\">https:\/\/repositorio.ulisboa.pt\/bitstreams\/c6cce407-960c-4042-aaf1-9624d6372c2c\/download<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[345] EU MDR and IVDR Notified Body Processes and Transition Periods (source nr: 345)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/medfilesgroup.com\/mdr-and-ivdr-notified-body-processes\">https:\/\/medfilesgroup.com\/mdr-and-ivdr-notified-body-processes<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[346, 366] medicaldeviceslegal | Medical devices legal and regulatory blog (source nr: 346, 366)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/medicaldeviceslegal.com\/page\/2\">https:\/\/medicaldeviceslegal.com\/page\/2<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[348] isrg-20251231 &#8211; SEC.gov (source nr: 348)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1035267\/000103526726000010\/isrg-20251231.htm\">https:\/\/www.sec.gov\/Archives\/edgar\/data\/1035267\/000103526726000010\/isrg-20251231.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[349] Medical Device Certification &gt; &#8211; Latest News &#8211; NSAI (source nr: 349)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.nsai.ie\/certification\/medical-devices\/latest-news\">https:\/\/www.nsai.ie\/certification\/medical-devices\/latest-news<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[350] Notified Body Audits: A Guide for Medical Device Manufacturers &#8211; MedEnvoy (source nr: 350)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/medenvoyglobal.com\/blog\/notified-body-audits-a-guide-for-medical-device-manufacturers\">https:\/\/medenvoyglobal.com\/blog\/notified-body-audits-a-guide-for-medical-device-manufacturers<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[356] 10-K &#8211; SEC.gov (source nr: 356)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1756262\/000119312526067032\/tmdx-20251231.htm\">https:\/\/www.sec.gov\/Archives\/edgar\/data\/1756262\/000119312526067032\/tmdx-20251231.htm<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[357] NIS2 Directive &#8211; Gain NIS2 Compliance with Sophos (source nr: 357)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.sophos.com\/en-us\/content\/nis2-compliance\">https:\/\/www.sophos.com\/en-us\/content\/nis2-compliance<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[360] The European AI Act: Requirements for High-Risk AI Systems (source nr: 360)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.emergobyul.com\/news\/european-ai-act-requirements-high-risk-ai-systems\">https:\/\/www.emergobyul.com\/news\/european-ai-act-requirements-high-risk-ai-systems<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[364] EU MDR PRRC Guide: Article 15 Responsibilities and 2026 Changes (source nr: 364)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/meddeviceguide.com\/blog\/eu-mdr-prrc-person-responsible-regulatory-compliance-guide\">https:\/\/meddeviceguide.com\/blog\/eu-mdr-prrc-person-responsible-regulatory-compliance-guide<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[367] 2024 Annual Report &#8211; Dentsply Sirona (source nr: 367)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/investor.dentsplysirona.com\/static-files\/0d4ca110-18df-4dcc-85d4-ca53822531c8\">https:\/\/investor.dentsplysirona.com\/static-files\/0d4ca110-18df-4dcc-85d4-ca53822531c8<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[369] European Union Regulatory Updates &#8211; TraceLink (source nr: 369)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.tracelink.com\/resources\/resource-center\/regulatory-updates\/european-union-regulatory-updates\">https:\/\/www.tracelink.com\/resources\/resource-center\/regulatory-updates\/european-union-regulatory-updates<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[370] SCDDA Solutions for Compliance &#8211; Assent (source nr: 370)<br>URL:&nbsp;<a target=\"_blank\" rel=\"noopener\" href=\"https:\/\/www.assent.com\/solutions\/esg-supply-chain\/scdda\">https:\/\/www.assent.com\/solutions\/esg-supply-chain\/scdda<\/a><\/p>\n<\/details>\n","protected":false},"excerpt":{"rendered":"<p>Basierend auf den bereitgestellten regulatorischen Rahmenbedingungen und Branchenkunden weisen der Cyber Resilience Act (CRA) und die Medizinprodukteverordnung (MDR) eine hochgradig deckungsgleiche strukturelle Architektur auf, obwohl sie unterschiedliche Produktkategorien regeln. Nachfolgend ist ein detaillierter Vergleich ihrer Gemeinsamkeiten aufgef\u00fchrt, gefolgt von dokumentierten Beispielen und Konsequenzen im Zusammenhang mit der MDR-Nichteinhaltung f\u00fcr mittelst\u00e4ndische und kleine Unternehmen. Strukturell\u2026<\/p>","protected":false},"author":865,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1060,403],"tags":[1061,1063],"class_list":["post-32195","post","type-post","status-publish","format-standard","hentry","category-cra-cyber-resilience-act","category-electronics-legislation","tag-cra","tag-cra-scope"],"_links":{"self":[{"href":"https:\/\/pi3g.com\/de\/wp-json\/wp\/v2\/posts\/32195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pi3g.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pi3g.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pi3g.com\/de\/wp-json\/wp\/v2\/users\/865"}],"replies":[{"embeddable":true,"href":"https:\/\/pi3g.com\/de\/wp-json\/wp\/v2\/comments?post=32195"}],"version-history":[{"count":1,"href":"https:\/\/pi3g.com\/de\/wp-json\/wp\/v2\/posts\/32195\/revisions"}],"predecessor-version":[{"id":32196,"href":"https:\/\/pi3g.com\/de\/wp-json\/wp\/v2\/posts\/32195\/revisions\/32196"}],"wp:attachment":[{"href":"https:\/\/pi3g.com\/de\/wp-json\/wp\/v2\/media?parent=32195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pi3g.com\/de\/wp-json\/wp\/v2\/categories?post=32195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pi3g.com\/de\/wp-json\/wp\/v2\/tags?post=32195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}